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Abstract
Infectious diseases and cancers frequently cause public health concerns and high burdens
on health care globally. Early diagnosis of these diseases can provide an important guide on
prevention, treatment, and prognosis in clinical practice. However, current laboratory diagnostic
methods, such as nucleic acid- and protein-based detection methods, require sophisticated
infrastructure, expensive and bulky instrumentation, well-trained personnel, and time-consuming
processes, which significantly leads to high cost of detection assays and limit their wide
accessibility, especially in low-resource settings. To address these issues, we have developed
multiple simple, low-cost, and visual quantitative diagnostic methods based on nanomaterialmediated photothermal effects for the detection of infectious diseases (tuberculosis and hepatitis
C) and cancer (prostate cancer).
Based on nanomaterial-mediated photothermal effects, quantitative disease diagnosis has
been achieved by only using a common thermometer or a low-cost hybrid microfluidic device.
On one aspect, photothermal effects have been conventionally applied in therapeutic strategies
due to the unique property of converting photon energy to thermal energy; whereas, there are few
reports regarding the quantitative biomolecular detection applications. In this dissertation, we
have studied the fundamentals of nanomaterial-mediated photothermal effects, established the
photothermal biosensing principles, and explored their applications in quantitative disease
diagnoses using a thermometer. On the other hand, microfluidic lab-on-a-chip (LOC) technology
provides a great opportunity for biomolecular detection, with numerous benefits including low
reagent consumption, miniaturization, and portability. Recently, hybrid microfluidic devices
have great potential in the point-of-care (POC) diagnostic applications because of combining
advantages from multiple chip substrates. Herein, we integrated the photothermal biosensing
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methods on hybrid microfluidic devices for quantitative diagnostics of both infectious diseases
and cancers at the point of care.
We, for the first time, developed a simple and universal photothermal biosensing method
for the quantitative detection of Mycobacterium tuberculosis (MTB) DNA using a thermometer.
By applying gold nanoparticle (AuNP) aggregation as a strong photothermal probe, the target
nucleic acids were detected using an inexpensive thermometer upon the irradiation of a nearinfrared (NIR) laser. High sensitivity was obtained with the limit of detection (LOD) of 0.28 nM,
which was nearly 10-fold higher than that from a colorimetric method using a costly
spectrometer. This method was further validated by testing various types of pathogenic nucleic
acids, demonstrating its universality with good analytical recoveries while avoiding the use of
bulky and expensive instrumentation.
Furthermore, by using a simple paper/polymer hybrid microfluidic device, we, for the
first time, developed a miniaturized, low-cost, and rapid quantitative method based on AuNPmediated photothermal effects for the on-chip detection of MTB DNA using a thermometer. A
simple one-step surface modification method was applied to immobilize DNA capture probes on
paper, while the target MTB DNA was dual-hybridized with capture probes and AuNP-modified
detector probes on the hybrid device. A strong photothermal agent, the oxidized TMB (3, 3, 5, 5tetramethylbenzidine) (ox-TMB) was then produced from the AuNP-catalyzed reaction. Under
the NIR laser irradiation for 3 min, this on-chip photothermal genetic analysis can be achieved
using a thermometer, with higher sensitivity than conventional colorimetric methods while with
no issues of color interference.
In addition to genetic analyses, we also developed the photothermal applications in
protein-based diagnostics. A low-cost and portable immunosensing method based on Fe3O4 NP-

ix

mediated photothermal effects was developed for the detection of the hepatitis C virus core
antigen (HCVAg). Iron oxide nanoparticles were introduced in a conventional immunoassay (the
direct ELISA (enzyme-linked immunosorbent assay)) and used as the peroxide-mimicking
nanozymes to produce the photothermal probe, ox-TMB. Under the irradiation of a portable NIR
laser, the photothermal detection of HCVAg was achieved using a common thermometer,
demonstrating good analytical performance with high sensitivity and specificity, which were
comparable to the results obtained from the commercial diagnostic kit using a bulky and
expensive microplate reader.
At last, we integrated the photothermal immunoassay with microfluidics and developed
an immuno-PT-Chip (a photothermal effect-driven volumetric bar-chart immunosensing
microchip) for visual quantitative detection of cancer biomarkers. In this strategy, Prussian blue
nanoparticles (PB NPs) derived from a typical sandwich immunoassay served as a strong NIR
photothermal probe. The immunosensing signals were converted to visual bar-chart movement
distances on the immuno-PT-Chip due to heat generation and accumulation of vapor pressure
under NIR laser irradiation. The quantitation of the target prostate-specific antigen (PSA) was
achieved by directly recording the moving distance on the immuno-PT-Chip, without the aid of
any bulky and expensive instruments or even a thermometer. High specificity and sensitivity
were achieved with the LOD of 2.0 ng/mL, which met the requirement for clinical PSA testing.
Good performance was verified by testing PSA in human serum and whole blood samples. The
exploration of the immuno-PT-Chip provides significant advances for the POC diagnostic
detection of biomarkers using microfluidics.
In sum, we have established the photothermal detection principle for genetic analyses and
immunoassays and developed different photothermal biosensing methods, in which low-cost
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POC detection of disease biomarkers has been achieved by simply using a common thermometer
or low-cost hybrid microfluidic devices, alleviating the need for any bulky instruments and
professional personnel. This dissertation provides great potential for POC disease diagnosis
based on nanomaterial-mediated photothermal effects and opens new possibilities in the
development of simple, reliable, and low-cost disease diagnostic platforms, particularly in
resource-poor settings with health system constraints.
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Chapter 1: Introduction
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1.1

Disease diagnosis
Human diseases, as referring to and associated with the dysfunction of the body’s normal

homeostatic processes, can cause different signs and symptoms, and lead to severe burdens in
global public health.1,2 To date, research scientists have made numerous efforts in discovering,
identifying, and understanding human diseases and their biology as well as mechanisms due to
the rapid development of biomedical and clinical research studies, which plays a significant role
in the disease control and prevention.3 Among all defined diseases, infectious diseases and
cancers are two major constituents and cause severe concerns, leading to high morbidity and
mortality.
Infectious diseases caused by pathogenic microorganisms, including bacteria, viruses,
parasites, and fungi, could be spread directly or indirectly from one individual to another.
Various types of infectious diseases have been found in human history, from ancient smallpox,
plagues, human immunodeficiency virus infection and acquired immune deficiency syndrome
(HIV/AIDS), Ebola hemorrhagic fever, Nipah virus encephalitis, severe acute respiratory
syndrome (SARS), to the most recent coronavirus disease 2019 (COVID-19).4,5 When
encountering these diseases and even outbreaks, significant challenges have been launched with
the devastating loss of human lives, massive economic cost, and large political shocks. Although
most infectious diseases only last a short period of time, they can be quite serious and even fatal,
resulting in a leading cause of global morbidity and mortality.6 According to the statistics,
between 1980 and 2014, there were over 4 million deaths reported due to infectious diseases in
the United States.7 Despite the improved healthcare infrastructure and preventive measures (like
vaccines), infectious diseases remain an ever-present and indisputable public health threat in
daily life.8
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Another major type of human disease is caused by cancer, which contains a large
collection of genetic diseases, including lung, colon, breast, liver, and prostate cancers. Cancer is
usually caused by gene mutations and leads to abnormal cell growth. Cancer is among the
leading causes of death across the world which is responsible for an estimated 9.6 million (1 in
6) deaths in 2018 according to the World Health Organization (WHO); the world has seen that
cancer surpass other diseases (e.g. heart disease) as the No. 1 killer in some middle- and highincome countries according to a recent study.9 Fortunately, cancer mortality can be reduced with
the early diagnosis and the timely treatment, where common diagnostic tests have been applied
such as laboratory tests (e.g. blood, urine, etc.), biopsy, and imaging techniques (e.g. X-rays,
Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI), etc.).
Regardless of different types of diseases, disease diagnosis is a priority in clinical
practice to provide important information for medical decisions and pharmacological treatments.
Currently, in addition to the physical examination conducted by doctors and other health-care
professionals, laboratory molecular tests, as advanced detection methods, have been extensively
investigated and applied in varying disease diagnostic platforms, with numerous benefits of
providing an important guide to diagnose, treatment, and prognosis in clinical applications.10
One typical example of laboratory molecular tests is nucleic acid testing, which has been
commonly used to screen and diagnose COVID-19 in most countries during the ongoing global
pandemic.11,12 Unfortunately, many health systems in middle- and low-income countries are still
struggling to access timely and quality diagnosis and treatment. Therefore, it is still a
considerable challenge and imperative to develop reliable, rapid, and low-cost diagnostic
strategies, especially in low-resource settings.
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In the following sections, based on different biomolecules commonly tested in laboratory
detection procedures, two major diagnostic methods have been summarized and briefly discussed
for the diagnostics of both types of diseases, specifically involving nucleic acid-based and
protein-based diagnostic methods.
1.1.1 Nucleic acid-based diagnostic methods
Nucleic acids, such as DNA and RNA, as the major genetic materials, have been widely
used in laboratory testing for disease diagnosis. Nucleic acid analyses enable the relatively rapid
and reliable detection of etiologic agents from clinical samples, and also allow sensitive
identification of pathogens. However, in practical applications, there are always limited amounts
of nucleic acids available for genetic analysis, especially at the early stage of diseases. Therefore,
the majority of nucleic acid-based tests rely on DNA or RNA amplification techniques.
The polymerase chain reaction (PCR) technique currently remains well recognized and
has been broadly applied in nucleic acid amplification-based methods for various disease
diagnostics.13 PCR is an important technique to amplify DNA segments, which was developed in
the 1980s by Kary Mullis,14 and then became a revolutionary method widely used in biological,
forensic, and clinical applications. Basically, given a sample DNA as templates, high
temperature (95 °C) is applied to denature the original DNA and obtain two pieces of singlestranded DNA. With the guidance of specific primers starting an annealing step (50-65 °C), new
strands of DNA complementary to the original target sequence can be synthesized by DNA
polymerase (such as Taq DNA polymerase) in an extension step (e.g. 72 °C). With the increasing
number of PCR cycles, DNA replicas are produced in an exponential manner, which finally
reaches to a drastic increase of DNA copies. Alternatively, when amplifying RNA, reverse
transcription PCR (RT-PCR) is used,15 and includes the reverse transcription of RNA templates
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into single-stranded complementary DNA (cDNA) by the reverse transcription enzyme, the
conversion of single-stranded cDNA into double-stranded DNA by DNA polymerase, and
similar PCR steps as abovementioned.
Quantitative detection of nucleic acids plays a vital role in the disease diagnostic
applications with numerous benefits. Importantly, it can provide not only the information about
whether the disease exists but also how the disease’s severity is. For example, real-time PCR has
been used in tumor cell analysis by detecting a type of genes, CK19 mRNA, which could
identify primary breast cancer from the advanced stages, leading to a reliable disease diagnosis
report and predictive treatment strategy.16,17 Additionally, real-time PCR or quantitative PCR
(qPCR) is extremely useful in practical applications, which enables the detection of amplification
products of nucleic acids (usually labeled with fluorescent reporters) during each cycle of the
amplification process, and obviates the need of cell culture procedures as well as the usage of gel
electrophoresis to identify sequences.
Despite these advantages of the above nucleic acid amplification-based diagnostic
methods, there are some obvious limitations, which keep them from being adopted more widely
in disease diagnosis.15 For example, the major drawbacks in the PCR-based genetic detection are
the need of costly and sophisticated instrumentation, skilled personnel, specialized laboratories,
etc.18 One qPCR equipment may cost over $50, 000 itself, excluding extra costs of accessories
(e.g. cartridges), detection reagents, and other supplies, which are all comprised of the total cost
in sample testing. It is therefore urgent to establish new analytical methods for reliable and lowcost nucleic acid analysis, such as using smartphone-based testing platforms,19-21 which provide
comparable sensitivity yet negate the need for any expensive instrumentation, and are suitable
for broadly applications, especially in the poor-resource areas.
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1.1.2 Protein-based diagnostic methods
Protein, a major and abundant component in blood serum or plasma, is another type of
important biological molecule relevant to human disease. The alternations in serum proteins may
cause a wide range of health disorders and diseases, such as chronic infections. Hence, it is of
significance to evaluate the quantification, characteristics, and physiological functions of
proteins for disease diagnosis.22,23 The enzyme-linked immunosorbent assay (ELISA) is the most
important protein-based quantitative detection method based on the antigen-antibody interaction,
which was first described and introduced in the 1970s by Peter Perlmann and Eva Engvall.24,25
Typically, a target antigen is first immobilized on a solid surface (e.g. a microtiter plate or a
plastic tube). An enzyme-linked antibody is then utilized to specifically bind the antigen directly
or indirectly, during which the antibody amount is proportional to the antigen amount. A
substrate, such as the chromogenic substrate 3,3’,5,5’-tetramethylbenzidine (TMB),26 is usually
added after the immuno-recognition process, and converted to a detectable (e.g. colored) product
by the enzyme, which usually belongs to either natural enzymes (like horseradish peroxidase or
HRP) or artificial enzymes (like nanozymes).27,28 Therefore, the target substance (e.g. peptides
and proteins) can be quantified by spectrophotometrically measuring the product using optical
densities or absorbances as signals.
Ever since its evolution, ELISA has been intensively studied and broadly applied in a
variety of research fields, including basic immunology,29 diagnostics,30,31 food safety
analysis,26,32

toxicology,33

vaccine

development,34

and

pharmaceutics.35

Particularly,

unambiguous advantages arise from the diagnostic application of ELISAs, when taking the
detection of biomarkers (e.g. prostate-specific antigen (PSA) as an example).36 By evaluating the
biomarkers as a specific indicator of normal biological or pathogenic processes, or
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pharmacological responses to a therapeutic invention,37-39 crucial information can be provided
regarding screening, disease diagnosis, and treatment, which further guides prognostic and
therapeutic decisions.
Currently, according to different substrates involved in ELISAs, various detection
methods have been developed for disease diagnostics, such as surface plasmon resonance
(SPR),40

colorimetry,41,42

fluorescence,43

electrochemistry,44

and

chemiluminescence.45

Unfortunately, most conventional methods have posed limitations to the widely point-of-care
(POC) application, especially in resource-constrained settings, mainly due to the reliance on
expensive biochemicals (e.g. enzymes), trained and skilled personnel, as well as costly and bulky
analytical instruments (e.g. microplate reader). Therefore, there has been a sustained need for
developing novel immunoassay strategies for the low-cost, simple, and portable POC detection
of biomarkers.
1.2

Nanomaterial-mediated photothermal effects
Nanotechnology has significantly advanced the development of molecular testing for

disease diagnosis, including both nucleic acid-based and protein-based detection methods. To
date, a wide variety of nanomaterials have been applied in molecular diagnostic platforms, such
as gold nanoparticles, due to their unique characteristics (e.g. plasmonic properties),
functionalities (e.g. enzyme-like activity), and capabilities (e.g. facilitating transduction from
molecular recognition to biosensing signals).46,47
1.2.1 Fundamentals of photothermal effects
Photothermal effect is defined as a phenomenon of materials produced by
photoexcitation, which results in the production of heat, according to the International Union of
Pure and Applied Chemistry (IUPAC).48 In principle, these materials can absorb photon
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irradiation in a specific frequency range of light and convert it to thermal energy, resulting in a
temperature increase.49 Photothermal effects have been broadly utilized in scientific research and
industrial

applications.

One

typical

example

is

the

development

of

photothermal

spectroscopy.50,51 By checking temperature changes or related indexes using thermal detection
techniques, samples, even containing trace chemicals,52 can be analyzed via spectroscopic
measurement under the irradiation of laser beams.
These materials, which can efficiently absorb and convert certain wavelengths of light
into heat, have been explored as photothermal agents. Currently, there are different types of
photothermal agents, involving both inorganic and organic materials, whereas plasmonic
nanomaterials and organic dyes are the most popular categories due to their easily accessible
synthesis methods, flexible photophysical properties, and broad applications in chemical,
biological, and biomedical analyses.
In recent decades, the photothermal effects of plasmonic nanomaterials have been amply
investigated, especially due to the rapid development of nanotechnology. A vast number of
nanomaterial-involved photothermal agents have been explored, such as Prussian blue
nanoparticles (PB NPs),53 gold-based,54,55 and carbon-based nanomaterials,56 which have unique
properties of light-to-heat conversion because of the plasmonic structure. Particularly, these
plasmonic nanomaterials have strong absorption in the NIR region due to the localized surface
plasmon resonance (LSPR), which is the result of the interaction of nanomaterials with the light
of resonant frequency. The conversion from light to the heat of plasmonic nanomaterials
undergoes a series of photophysical processes, as shown in Figure 1.1A.57 Typically, upon the
irradiation, the resonant light is absorbed by nanomaterials, and strong surface fields are induced
owing to the coherent excitation of electrons in the nanomaterials. As such, free electrons exhibit
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a collective and strong oscillation at the surface of nanomaterials during the rapid relaxation
process, including the electron-electron relaxation and the electron-phonon relaxation. The
localized heat is produced and then dissipated rapidly from the particles (via phonon-phonon
relaxation) into the surrounding media to heat species around the nanomaterials.54,58 High
photothermal conversion efficiency could be obtained by controlling the size, shape, and surface
coating groups of nanomaterials.
Besides plasmonic nanomaterials, some small organic dyes have emerged as a viable
candidate for photothermal agents,59 such as indocyanine green,60 croconaine,61 and
polypyrrole,62 and TMB.42 For these organic photothermal agents, most of these absorb light at
certain wavelengths and undergo rapid conversion to the lowest excited singlet state (S1)
followed by the photoexcitation. The working principle is shown in Figure 1.1B. While decaying
back, different pathways could be followed including emitting a photon (back to the ground
state, i.e. fluorescence), intersystem crossing to a triplet state, T1 (i.e. phosphorescence), or going
through non-radiative relaxation pathways (i.e. photothermal effects). It is noted that the heat
generation from photothermal effects could be unimolecular or induced by collisions between the
excited singlet species and the surroundings.59 Compared to plasmonic nanomaterials, these
organic photothermal agents have good biocompatibility and biodegradability, whereas poor
photothermal stability and multistep synthetic process limits their applications.
Taking into account both types of the aforementioned photothermal agents, it is still a
formidable challenge to apply photothermal effects in practical applicability, especially in the
development of novel applications, such as the quantitative biomolecular detection for disease
diagnosis. Therefore, to circumvent this issue, we have studied different types of photothermal
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agents, investigated their fundamentals, and explored their nanomaterial-mediated photothermal
applications for quantitative disease diagnosis.

Figure 1.1: Working principle of (A) plasmonic nanostructures-based photothermal effects and
(B) organic molecules-based photothermal effects. (Source: (A) Adapted with
permission from Webb et al., 2014. Copyright @ 2014 The Royal Society of
Chemistry.57 (B) Adapted with permission from Jung et al., 2018. Copyright @
2018 The Royal Society of Chemistry.59)
1.2.2 Applications of photothermal effects
To date, the photothermal effect has been applied in several fields, including the ablation
of cancer cells,63 in vivo drug delivery,64 killing bacteria,65 and cross-linking of polymer
networks,66 which intuitively rely on the heat generation of photothermal agents under irradiation
of lasers. For example, photothermal effects have been extensively exploited in biomedical
applications, namely the photothermal therapy (PTT). Particularly, the NIR-induced
10

photothermal effects have attracted more interest, because the NIR region (700-1,000 nm), as a
biological window, possesses considerable merits of low light scattering, minimal adsorption,
and the optimal penetration depth in living cells and tissues.67 During photothermal therapy,
photothermal agents are first injected to target cancerous cells, and heat is generated under the
irradiation of NIR lasers due to the specific absorption and light-to-heat conversion of these
materials. The generated heat is initially localized and then transferred into the surrounding
media, which can be further employed to kill cancer cells with the benefits of minimal
invasiveness and potential effectiveness.53 This treatment is also known as the hyperthermia
treatment, which usually heats the target region to a temperature range of 41-47 °C (or even
higher) in several to tens of minutes,68 based on the choice of photothermal agents and irradiation
circumstances.
Derived from this basic principle, different PTT strategies have been reported in
hyperthermia treatments, while imaging-guided PTT is the most widely used method. Thermal
microscopy and cameras are broadly adopted in imaging-guided PTT owing to its simplicity and
straightforward readouts.69 For example, polyaniline nanoparticles (PANPs) were modified to
prepare photothermal agents, F-PANPs, which were applied in the NIR-induced PTT.70
Photothermal images of F-PANPs were obtained using a FLIR (forward-looking infrared)
camera upon laser irradiation, with temperature signals obtained directly from the thermal
radiation (Figure 1.2). With an increasing amount of F-PANPs, photothermal images of samples
displayed different colors from purple to bright yellow within 5 min of irradiation by an 808 nm
laser, representing changes from low temperature (20 °C) to high temperature (50 °C). The
results revealed that F-PANPs could absorb and convert the photon energy in the NIR range to
heat, during which the process was depended on concentrations of photothermal agents. The
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photothermal conversion efficiency of F-PANPs was obtained as 48.5% with good
photostability. The in vitro tests were performed using human colon carcinoma cells (HCT116),
which were incubated with F-PANPs samples and followed by laser irradiation. The results
showed cancer cells were killed during PTT within 15 min of laser irradiation. This method was
also employed in in vivo tests by intratumorally injecting F-PANPs into mice. Upon 5 min of
laser irradiation, a rapid temperature increase of 17 °C was observed, resulting in 48.8 °C of
localized temperature to kill tumors, while the temperature of surrounding normal tissues
increased only 1.8 °C. This work provided a typical and promising photothermal agent, which
met the general standards for PTT like high photothermal conversion efficiency, good
photostability, low toxicity, and suitability for both in vitro and in vivo testing.
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Figure 1.2. Conventional applications of photothermal effects for imaging-guided PTT. Thermal
imaging-guided PTT including the working principle and detection results under
laser irradiation within 5 min. (Source: (A) Adapted with permission from Zhou et
al., 2013. Copyright @ 2013 Elsevier.70)

In addition to thermal imaging-guided PTT, luminescence imaging-guided PTT has also
attracted much attention recently due to its high sensitivity and versatile detection functions.71,72
For instance, Pu et al. applied a semiconducting polymer nanococktail (SPNCT) for afterglow
luminescence imaging-guided photothermal therapy.71 The SPNCT nanococktail was synthesized
from two compartments, a temperature-monitoring sensor (poly(ethylene glycol) grafted
poly(phenylenevinylene), or PPV‐PEG) and a NIR photothermal agent (poly(silolodithiophene‐
alt‐diketopyrrolopyrrole, or PCSD). PCSD with a charge-transfer backbone structure facilitated
not only the nonradioactive deactivation, but also the heat generation after light excitation. Upon
NIR light pre-irradiation, the SPNCT converted photon energy into heat efficiently, while the
afterglow imaging monitored the real-time temperature increase and guided the photothermal
therapy, offering a sensitive in vivo detection of the tumor with less interference from tissue
autofluorescence and laser irradiation. Within 5 min of laser irradiation, the 4T1-tumor bearing
mice showed significant temperature increase as well as enhanced afterglow luminescence
signals, which were correlated in a linear relationship. The results proved both high PTT efficacy
and quantitative monitoring of temperature-dependent afterglow signals, even in deep tissues.
In the past decade, in order to expand more effective applications in PTT, a new concept
has been made to combine diagnostics and therapeutics based on photothermal effects, which is
known as the photothermal theranostic. Different imaging techniques have been exploited in
photothermal theranostics, involving photoacoustic,73-76 ultrasound,73 CT,77,78 MRI,79 or the
combination of multiple imaging modes.80 Despite the well-established platforms as
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abovementioned, unfortunately, the applications of photothermal effects have been constrained
in limited fields of photothermal therapy-based applications. However, in addition to the
primordial usage, photothermal effects are expected to highlight the competence in more
research areas, such as the easily accessible and applicable quantitative detection methods.
To expand more applications of photothermal effects, our group, for the first time, has
introduced the concept of nanomaterial-mediated photothermal effects for quantitative
bioanalysis. Up to now, different materials, such as PB NPs81, ox-TMB42, and AuNP
aggregates,82 were studied and defined as nanomaterial-mediated photothermal agents. It is noted
that PB NPs and AuNP aggregates exhibit strong photothermal effects in the NIR region due to
the plasmonic nanostructures, while ox-TMB is known as a promising organic photothermal
agent, which was generally produced via the metal nanoparticle (i.e. AuNPs and Fe3O4 NPs)catalyzed reactions and derived from the conventional ELISAs. We, for the first time, discovered
the photothermal effect of ox-TMB. By applying these nanomaterial-mediated photothermal
agents, several photothermal bioanalysis methods have been developed for various disease
diagnoses, in which only a thermometer was needed as the quantitative signal reader. For
example, by introducing PB NPs into a sandwich ELISA, the detection of a prostate cancer
biomarker, the prostate-specific antigen (PSA), was achieved by simply recording the
temperature elevation based on the photothermal effect.81 The complicated immunosensing
signals were thus converted into accessible temperature signals. Quantitative detection of
protein-based biomarkers was achieved using this platform for cancer screening and diagnoses
with high sensitivity and specificity, while avoiding the need for any expensive and specialized
laboratory equipment, like microplate readers.
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Ever since the first attempt to unveil the photothermal biomolecular detection strategy,
several platforms have been explored for the purpose of disease diagnostics, which have focused
on protein-based photothermal immunoassays.42,83,84 There is a lack of explorations for detecting
other types of biomolecules related to disease diagnosis, such as nucleic acids. Moreover, current
photothermal biosensing platforms have mainly applied for cancer diagnosis, while more
applications of nanomaterial-mediated photothermal effects are expected to be developed, for
instance, for the timely diagnosis of infectious diseases. Therefore, this dissertation explores the
quantitative photothermal detection of both nucleic acids and proteins for the diagnosis of
different diseases, including infectious diseases and cancers.
1.3

Microfluidic platforms
Microfluidic lab-on-a-chip (LOC) technology provides a great opportunity for the

quantitative detection of biomolecules with numerous features, such as low reagent consumption,
miniaturization, a high degree of integration, portability, rapid analysis, etc. Since the early
1990s, there have been enormous chemical, ecological, biological, and biomedical applications
of microfluidics, including food safety monitoring, environmental surveillance, disease
diagnostics, and therapeutics.13,85-87 Particularly, in the last few decades, rapid development has
emerged using microfluidic platforms as a powerful POC diagnostic tool to deal with various
public health issues, especially in poor-resource regions.21,31,88-91
1.3.1 Microfluidic device evolution
The choices of microfabrication substrates as well as related techniques play a vital and
fundamental role in the evolution of microfluidic platforms to meet assorted requirements for
POC applications.92-96 Silicon was used to fabricate the first generation of microfluidic devices,
which was originated from the well-established microelectromechanical techniques in the
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semiconductor industry. Several properties like hardness, chemical resistance, and thermal
stability make it suitable for the fabrication of silicon-based microfluidic devices, which
generally possess electrical components and functionality. As an example, a silicon-based
microfluidic device was developed for proteomics research by integrating a reversed-phase
separation column and a nano-electrospray emitter.97 The device was fabricated using silicon
wafers via photolithography, which had high conductivity to generate electrospray when
applying an electric potential to sample solutions. The performance of the integrated device in
electrospray and separation was investigated by interfacing with a mass spectrometer. Stable
electrospray was obtained and compatible with various mobile phases from 100% water to 40%
acetonitrile aqueous solvents. The efficient separation was found with a high retention capacity
and reproducibility, which was comparable to the standard column. This microfluidic platform
was further validated by separating and analyzing the tryptic digests of cytochrome c with no
pre-concentration process.
Glass was soon found wide applications in the fabrication of microfluidic devices, even
outperforming silicon, mainly because of its excellent optical transparency, organic solvent
resistance, and the capability of efficient coatings.92 Specifically, glass has been commonly used
in the fabrication of LOC devices for genetic analyses in DNA microarray, which relies on the
solid-phase hybridization technology.98 Through in situ synthesis or microprinting of
oligonucleotides, the DNA microarray can be constructed by immobilizing DNA probes directly
on the surface of glass slides, or with the aid of electrodes microfabricated on the glass.99 Target
nucleic acids with complementary sequences are recognized due to DNA hybridization, which
can be detected using the majority of analytical measurements, such as colorimetry,100
fluorescence,101 electrochemistry,102 and electrochemiluminescence.99 In addition, DNA
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microarray using glass-based microfluidic devices can provide multiple intensive hybridization
sites on a single chip and significantly increase the detection capacity, which is promising to
promote the high-throughput analyses for nucleic acids. For example, a glass-based microfluidic
device was developed by Li et al. for the detection of three types of pathogenic DNA samples.103
The glass was modified to create aldehyde groups on the surface and used for covalent
immobilization of aminated DNA probes. Through microprinting techniques, 16 oligonucleotide
probe line arrays were obtained per chip. Rapid hybridization occurred between the probe lines
and sample channels within minutes, and sensitive fluorescence detection was achieved to
discriminate samples with a one-base pair mismatch.
Both silicon- and glass-based microfluidic devices can be fabricated through traditional
microfabrication techniques, such as the standard photolithography.104 Despite variations in
detailed protocols, there are several fabrication procedures in common during photolithography,
involving cleaning substrates, applying photoresist, aligning photomasks, photo exposure, wet or
dry etching, and assembly. However, specialized infrastructure such as the cleanroom facility,
hazardous chemicals (e.g. piranha solution and hydrofluoric acid), and stringent conditions (e.g.
high temperature and pressure) are essential during the fabrication process, which has motived
the exploration of alternative substrates with a less stringent requirement for fabrication facility.
Polymers like thermoplastics and thermoelastomers have attracted much attention and
used as promising substrates in fabricating microfluidic devices,92 because of the relatively low
cost, flexible manipulation requirements, and capability for rapid prototyping. Particularly, poly
(methyl methacrylate) (PMMA) and polydimethylsiloxane (PDMS) are two kinds of polymer
substrates, which have been broadly employed in the fabrication of microfluidic devices for POC
applications. For example, a multi-channel PMMA-based microfluidic platform was reported by
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Baeymner and coworkers for the electrochemical detection of DNA.105 The platform consisted of
interdigitated ultramicroelectrode arrays (IDUAs) and multiple microchannels on PMMA
substrates and assembled via UV/ozone-assisted thermal bonding, which prevented the cross-talk
between multiple microchannels. In a sandwich type of DNA hybridization labeled with the
redox marker, target sequences were able to be detected within 250 s using this platform, with
the LOD of 12.5 µM. Alternatively, a PDMS-based microfluidic chip was developed for rapid
isolation and detection of circulating tumor cells (CTCs).106 To fabricate this chip, a highly
porous PDMS microfiltration membrane (PMM) was used as a middle layer, assembled with a
top cell capture chamber and a bottom waste chamber via plasma treatment, without the need for
complicated assembly or surface modification procedures. A uniform array of micro-holes in
PMMs with porosity up to 20% allowed the rapid and efficient processing of blood specimens in
a high-throughput manner (10 mL/h). By introducing human blood samples from inlets to the
chip, cells were filtered out through the PMM when applying a syringe pump. Specific dyes were
used to distinguish white blood cells (WBCs) and epithelial tumor cells, while CTCs were
captured by the fluorescence-labelled specific antibodies for further detection.
Paper, an ancient cellulosic material, has recently revived attractive applications in
microfluidics. Several outstanding advantages have been found using paper as the
microfabrication substrate, including the wide availability, superior low-cost, easy fabrication
process, intrinsic 3D porous microstructures, biodegradability, reusability, etc. Since the first
introduction of the concept for microfluidic paper-based analytical devices or µPADs by the
Whitesides group,107 there have been extensive studies to explore POC diagnostic applications
using µPADs. Typically, a paper-based microfluidic device was developed for DNA detection in
a colorimetric assay, which was based on pyrrolidinyl peptide nucleic acid (acpcPNA)-induced
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gold nanoparticle (AuNP) aggregation.108 The device consisted of four hydrophilic channels and
hydrophobic barriers, which were fabricated via wax printing. Two layers of the patterned paper
were assembled via origami, forming different colorimetric detection zones with acpaPNA probe
and AuNPs preloaded. Upon the addition of samples in the center reservoir, different colors were
observed due to the positively charged acpcPNA-induced AuNP aggregation in the absence of
target sequences and AuNP stabilization in the presence of target sequences. This platform was
applied to screen different DNA samples, including the Middle East respiratory syndrome
coronavirus (MERS-CoV), human papillomavirus (HPV), etc., achieving high sensitivity and
selectivity.
Despite numerous benefits of using paper-based microfluidic devices, there are also
issues preventing their wide applications. For instance, paper-based biological applications
generally require complicated, multistep, and laborious surface modification of paper substrates,
such as cross-linking reactions,109,110 for the covalent immobilization of biomolecules onto paper.
To solve this issue, our lab has developed a paper-based microfluidic device for pathogenic DNA
detection using a one-step surface modification method (Figure 1.3).111 By only using 3aminopropyl trimethoxysilane (APTMS), cellulose paper substrates were modified with the
positively charged amine groups, which could directly immobilize negatively charged DNA
probes via simple and robust ionic interactions. This platform provided higher immobilization
efficiency of DNA than that in glass-based microfluidic devices modified via complicated and
time-consuming crosslinking reactions. Besides, there was no need for complex functionality of
nucleic acid probes and target sequences, offering a universal platform for various genetic
analyses. Using this method, a paper-based microfluidic device was fabricated via
photolithography and modified by APTMS, which was successfully applied for the low-cost
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detection of foodborne pathogens (Giardia lamblia), demonstrating the excellent compatibility
for broad biological applications at the point of care.

Figure 1.3. A simple and low-cost paper-based microfluidic device for POC pathogen detection.
(A) Image of a patterned paper-based device using the photolithography method.
(B) Calibration curve of pathogen detection on the APTMS-modified paper-based
device, with positive controls (black), negative controls (red), and the PBS buffer as
a background (blue). Error bars represent standard deviations (n = 6). (Source:
Adapted with permission from Zhou et al., 2020. Copyright @ 2020 American
Chemical Society.111)
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1.3.2 Hybrid microfluidic devices
Although a wide range of applications have been found in the abovementioned
microfluidic platforms,87,90 there are always drawbacks when using a single substrate in the
microfabrication. For example, it takes a prolonged time and high cost when fabricating siliconand glass-based microfluidic devices. The surface micromachining of the PMMA-based
microfluidic devices results in patterns with fragility and low resolutions. The PDMS-based
microfluidic devices have faced problems like low solvent resistivity and channel deformation.112
There is commonly a lack of high performance in flow control of liquid samples on paper-based
microfluidic devices. Therefore, to obtain more features and functionality, the hybrid
microfluidic devices have been developed, particularly the paper/polymer hybrid devices first
introduced by our group,113 which have adopted merits from multiple substrates while avoiding
drawbacks of the individual substrate.13,31,86,90
By incorporating multiple materials in the microfabrication process, the hybrid
microfluidic devices are consequently contingent on a variety of requirements and applications.
Typically, good sealing performance can be achieved in the glass/PDMS hybrid microfluidic
devices, avoiding thermal bonding under high temperatures. The PMMA/PDMS hybrid
microfluidic systems can draw several benefits, such as mechanical stability, optical
transparency, and tunable gas permeability. The paper/PDMS hybrid devices are competent to
integrate different microstructures and elements, such as microchannels and microvalves, which
allow precise control in fluid flow.
Recently, the paper and polymer hybrid microfluidic devices have served as versatile
platforms and found widespread applications in many fields, such as nucleic acid analysis,114
protein detection,115 cellular analysis,113 3D cell culture,116 and organ-on-a-chip.117 As a pioneer,
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our lab has introduced several paper/polymer hybrid microfluidic platforms for different POC
diagnostic applications.31,90,91,113 For example, we previously designed a hybrid microfluidic
microplate device for the rapid quantitative detection of multiple disease biomarkers.31 The
device was fabricated using low-cost paper and polymer materials (PMMA), in which the usage
of porous paper in flow-through microwells facilitated rapid immobilization of antibodies and
antigens, avoiding the complicated surface modification process. By using delivery channels on
the microfluidic device, repeated manual transfer pipetting and costly robots were eliminated.
Quantitative analyses of target biomolecules were achieved by simply scanning and analyzing
images of the immunosensing areas, with no need for specialized equipment. In addition, the
POC analysis with high throughput could be also accomplished with tunable capacities of the
microfluidic devices, with comparable sensitivity to that obtained from the commercial ELISA
kits. Alternatively, a paper/PDMS/glass hybrid microfluidic biochip was designed and applied
for the rapid and portable diagnosis of respiratory diseases.19 To fabricate this biochip, glass
slides were used as the base support; two PDMS layers consisted of inlet/outlet reservoirs,
reagent delivery microchannels, and LAMP reaction zones; a piece of paper was inserted into
each detection zones with preloaded LAMP primers. The on-chip LAMP was performed by
using a portable heater, followed by shining a portable UV pen on the detection zones. The
fluorescence image was collected using a smartphone, which was further analyzed by using the
software ImageJ. By using this biochip, up to 100 clinical samples were used to validate this
method, achieving 96% of specificity and 100% sensitivity, which were comparable to the
results obtained by real-time PCR. This proposed hybrid microfluidic biochip, as a low-cost and
portable POC device, has a great potential in the rapid and instrument-free diagnostic
applications.
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Given unique merits from hybrid microfluidic devices, I propose two types of hybrid
microfluidic devices and applied them in accordance with specific requirements, including a
paper/PMMA microfluidic device (see details in Chapter 4) and a PDMS/PMMA microfluidic
device (see details in Chapter 6) for diagnostics of infectious diseases and cancers, respectively.
In particular, the use of paper has enabled the simple immobilization of DNA probes for the
infectious disease diagnosis, while PMMA was used as a support layer allowing sufficient
space/volumes for biosensing reactions. In the detection of cancer biomarkers, PDMS was used
to provide reversible and robust sealing of microchannels and microwells on PMMA plates,
which avoided the complicated bonding procedures and improved the reusability of the device.
1.3.3 The volumetric bar-chart microchip
Among a variety of the microfluidic POC devices, the volumetric bar-chart microfluidic
chips (V-Chips) have emerged as a promising platform for instrument-free bioanalyses in the
recent decade.118-123 Instead of using conventional colorimetric, fluorescence, or electrochemical
signals, these V-Chips have been designed integrating with ELISAs and provided on-chip barchart movements as analytical readouts, as shown in Figure 1.4. Currently, V-Chips are mostly
driven by gases (e.g. O2) generated via immunoassay-based catalytic reactions, from which the
gases provide a powerful driving force in the microfluidic pumping. This approach has allowed
the visual and quantitative detection of target biomolecules based on the direct volumetric
measurement of bar charts on the V-Chips, without the need for any optical instrumentation (like
microplate readers) and complicated data processing.
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Figure 1.4: Instrument-free microfluidic POC devices for biomolecular detection. Schematic
illustration of an assembled V-Chip (top left) and the immunosensing results on the
V-Chip (top right) after the slide oblique based on ELISA-induced gas generation
(bottom), and the oxygen generation mechanism on the V-Chip (bottom). (Source:
Adapted with permission from Song et al., 2012. Copyright @ 2012 Springer
Nature.118)

However, conventional V-Chips have been faced with their instinct disadvantages, such
as the relatively expensive microfabrication substrates (i.e. glass slides), complicated fabrication
procedures (e.g. cleaning and etching using hazard chemicals), costly preparation and
purification of catalase, vulnerability to environmental conditions (e.g. temperature and
atmospheric pressure), and low controllability on the gas generation.124 Hence, there is a critical
need for the development of new strategies to improve the V-Chips, such as simplifying the chip
designs and exploring robust driving forces.
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To address these issues, I propose a photothermal effects-driven volumetric bar-chart
microchip (immuno-PT-Chip) by applying nanomaterial-mediated photothermal effects in
microfluidics for the visual quantitative detection of biomolecules. Briefly, by integrating
conventional immunoassays with the immuno-PT-Chip, the photothermal probes can be used to
convert the light to heat under irradiation of lasers. The vapor pressure is then accumulated
causing the bar-chart movements within microchannels, which can be recorded directly by
reading the flow distances on the immuno-PT-Chip. Hence, the concentration of biomolecules
can be correlated with on-chip measurements, without the aid of any bulky and expensive
instruments. The integration of nanomaterial-mediated photothermal effects with microfluidic
systems provides new possibilities for simple, rapid, low-cost, and instrument-free bioanalysis.
More details regarding the proposed research can be referred to Chapter 6.
1.4

Research objectives
The ultimate goal of this research is to develop visual quantitative biosensing methods

based on nanomaterial-mediated photothermal effects for simple and rapid disease diagnostics.
By studying the fundamentals of nanomaterial-mediated photothermal effects, we have
successfully introduced several photothermal probes to quantitative biomolecular detection
methods, including both genetic analyses and immunoassays, and explored novel photothermal
diagnostic applications for infectious diseases and cancers. In addition, hybrid microfluidic
devices have been integrated with these detection methods, achieving rapid, low-cost, portable,
and instrument-free POC photothermal diagnostic platforms. The dissertation structure has been
organized with four research projects in Figure 1.5.
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Figure 1.5: The organizational structure of this dissertation.

Particularly, Chapter 2 summarizes major experimental sections in this dissertation. In
Chapter 3, a photothermal biosensing platform has been developed for the quantitative genetic
analysis of tuberculosis using a thermometer. By applying gold nanoparticle aggregations as the
photothermal probes, the target MTB DNA was detected directly using temperature signals as
analytical readouts with high sensitivity. Good specificity and analytical recoveries were
achieved when testing genomic DNA sequences with no assist of expensive and bulky
instrumentation. This work has also provided a universal platform for the detection of various
nucleic acids by simply using a thermometer.
We further integrated the photothermal nucleic acid analysis with a simple paper/polymer
hybrid microfluidic platform (see details in Chapter 4). With a one-step surface modification
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process on paper, the DNA probes targeting MTB sequences were simply immobilized on the
paper substrate for sandwich hybridization assays. Consequently, DNA probes-functionalized
AuNPs were then introduced on the paper detection zones and used as a peroxidase-mimicking
nanozyme to produce the photothermal probe, ox-TMB. Temperature increases of paper
detection zones were recorded using a thermometer and served as the analytical readout in the
quantitative DNA analysis. Therefore, this proposed photothermal biosensing method was
capable to detect low volumes of DNA samples without any DNA amplification procedures,
providing a simple, low-cost POC diagnostic approach.
Besides nucleic acids, we have also explored photothermal applications in the
quantitative detection of protein-based immunoassays. In Chapter 5, the immunosensing signals
in the traditional ELISA were converted to photothermal signals by applying iron oxide
nanoparticles as the peroxidase-mimicking enzyme, which led to the production of ox-TMB as
the NIR photothermal probe. Using a portable laser pointer and an inexpensive thermometer, the
sensitive and specific detection of the hepatitis C virus (HCV) core antigen was achieved with
great simplicity and good analytical performance, as compared to the conventional
immunoassays using costly analytical instruments.
In Chapter 6, we further demonstrated an equipment-free photothermal method for cancer
biomarkers (PSA) detection using an immuno-PT-Chip (or a nanomaterial-mediated
photothermal effects-driven volumetric bar-chart microfluidic chip). By transforming iron oxide
nanoparticles involved in a conventional ELISA into PB NPs, a powerful NIR photothermal
probe, the heat generated within the PDMS/PMMA immuno-PT-Chip under NIR laser
irradiation. The immunosensing solutions were then pumped to flow through microchannels due
to the accumulation of vapor pressure. The obtained bar-chart movements were employed as a
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straightforward readout, resulting in the on-chip detection of PSA. As such, the visual and
quantitative detection of biomarkers was accomplished on the immuno-PT-Chip, even without
the need for a thermometer. This immuno-PT-Chip provided high sensitivity and specificity,
which was comparable with the commercial ELISA kit using costly microplate readers.
Moreover, good performance was verified for the detection of PSA using the complex matrix,
like the human serum and whole blood samples. By apply photothermal effects in microfluidics
as a driving force, this work has demonstrated a simple, portable, effective, and instrument-free
POC diagnostic tool.
Chapter 7 summarizes this dissertation and provides perspectives on the photothermal
applications in visual quantitative disease diagnoses.
In short, this dissertation has presented thorough studies about the fundamental basics of
nanomaterial-mediated photothermal effects, and, for the first time, explored and systematically
evaluated the applications of photothermal effects in visual quantitative disease diagnoses. As an
innovative methodology in the field of biomolecular analyses, this approach can be
accomplished by using a commonly accessible thermometer, or a low-cost microchip (immunoPT-Chip), with no need for sophisticated instrumentation, professional operators, and specialized
laboratory infrastructure. We envisage that this strategy has tremendous potential in the
development of POC diagnoses for various diseases, and is competent to assist in solving public
health issues, especially in those poor-resource settings with limited medical resources.
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Chapter 2: Experimental Sections

•

This chapter introduces major experimental sections in the research projects.

•

Materials and reagents are summarized first in this chapter.

•

Nanomaterial preparation and bioconjugation procedures are then described in
this chapter.

•

The protocols of photothermal detection using thermometers are established
herein.
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2.1

Materials and reagents
Chemicals and materials, including Whatman No. 1 chromatography paper (200 x 200

mm), gold nanoparticles (AuNPs, 20 nm in diameter), tris (2-carboxyethyl) phosphine
hydrochloride (TCEP), 3, 3’, 5, 5’-tetramethylbenzidine (TMB), dimethyl sulfoxide (DMSO),
sodium phosphate dibasic, sodium dodecyl sulfate (SDS), bovine serum albumin (BSA), normal
human serum, Dulbecco’s phosphate-buffered saline (PBS buffer, 10 mM, pH 7.4), salinesodium citrate (SSC) buffer (20x, pH 7.0), anti-IgG antibody, and prostate-specific antigen
(PSA) were purchased from Sigma (St. Louis, MO, US). Citric acid monohydrate and 1-Ethyl-3[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC·HCl) were purchased from VWR
(Radnor, PA, US). Hydrogen peroxide (H2O2, 30% w/w), N-hydroxysulfosuccinimide (SulfoNHS), and potassium ferrocyanide (K4[Fe(CN)6]) were obtained from Fisher Scientific
(Hampton, NH, US). Hepatitis C virus core antigen (HCVcAg), anti-hepatitis C virus core
antigen-antibody (rabbit polyclonal primary antibody), monoclonal mouse anti-human PSA
antibody, and polyclonal rabbit anti-human PSA antibody were received from Abcam
(Cambridge, MA, US). Iron oxide nanoparticles (Fe3O4 NPs functionalized with carboxylic acid
groups, 30 nm in diameter) were purchased from Ocean NanoTech (San Diego, CA, US). The
silicone elastomer base and the curing agent (Sylgard 184) for the fabrication of
polydimethylsiloxane (PDMS) were obtained from Dow Corning (Midland, MI, US). Poly
(methyl methacrylate) (PMMA, 1.5 mm and 2.0 mm in thickness) was purchased from
Mcmaster-Carr (Los Angeles, CA, US).
Unless otherwise noted, all chemicals were used as received without further purification.
Milli-Q water (18.2 MΩ·cm) was used throughout all projects from a Millipore system (Bedford,
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MA, US). The pH values of all buffer solutions were determined using a pH meter purchased
from Fisher Scientific (Model AB15, Hampton, NH, US).
Other stock solutions were prepared as follows: TMB stock solution was prepared in
DMSO with a final concentration of 5 mg/mL and stored in the dark at 4 °C. DNA washing
buffer was prepared from 20x SSC buffer to a final concentration of 2x, containing 30 mM
sodium citrate, 0.3 M sodium chloride, and 0.1% SDS. DNA hybridization buffer was prepared
from 20x SSC buffer to a final concentration of 5x, containing 75 mM sodium citrate, 0.75 M
sodium chloride, 0.1% SDS, and 1% BSA. Citrate buffer (pH 4.5) was prepared to contain 0.1 M
citric acid and 0.2 M sodium phosphate and stored at 4 °C.
All synthetic oligonucleotide were produced from Integrated DNA Technologies
(Coralville, IA, US) and listed in the following chapters individually. The concentrations of all
DNA samples were determined using a NanoDrop spectrophotometer (Sigma-Aldrich, St. Louis,
MO, USA).
2.2

Nanomaterial-based bioconjugation procedures
The Fe3O4 NPs-antibody conjugates were prepared based on a modified process through

a standard carbodiimide reaction.81,125 Typically, the carboxyl groups functionalized Fe3O4 NPs
(0.25 mg/mL) were mixed with EDC (25 mg/mL) and Sulfo-NHS (30 mg/mL) for 0.5 h at room
temperature. Then the antibody (i.e. 40 µg of anti-IgG antibody or PSA polyclonal antibody) was
added to the mixture, followed by incubation for 1 h under gentle shaking. Bovine serum
albumin (BSA, 5%) was used as the blocking buffer to react with the mixture for 0.5 h, in order
to block the remaining active sites on Fe3O4 NPs. The obtained dispersion was finally
centrifuged at 13000 rpm for 10 min and washed three times. The Fe3O4 NPs-antibody
conjugates were redispersed in the PBS buffer to get the desired concentration based on different
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requirements and stored at 4 °C before using. The Fe3O4 NPs-antibody conjugates will be used in
Chapter 5 and 6.
2.3

Protocols of photothermal detection using a thermometer
The general photothermal detection protocol using a thermometer was established below.

Different nanomaterial-mediated immunoassays or genetic analyses were performed and
described in detail in the following chapters (Chapter 3-6). In the photothermal measurement, a
laser diode (808 nm, MDL-III-808, purchased from Opto Engine, Midvale, UT, USA) or a
portable laser pointer (808 nm, PL-E Pro, purchased from Jet Lasers Photonics Devices Co., Ltd,
Xi’an, China) was used as the NIR light source. (Follow laser safety precautions when using
lasers.) Figure 2.1 shows the photographs of the laser diode and the portable laser pointer,
respectively. By adjusting the laser power and the height from lasers to samples, different
volumes of sample solutions were irradiated accordingly.
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Figure 2.1: The photographs of (A) the 808 nm laser diode and (B) the 808 nm portable laser
pointer used in this dissertation.
A dual-input type digital thermometer (Model J/K 421502, Extech Instruments
Corporation, USA) was inserted to sample solutions upon the termination of irradiation to
monitor temperature changes. The photothermal detection setups are shown in Figure 2.2,
containing the irradiation source (the laser diode or the portable laser pointer), sample tubes, and
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the signal recorder (the thermometer). It was noted that the position of the thermometer probe
(around 1 mm in diameter) was fixed in each set of temperature measurements, which eliminated
the temperature variations from position to position when measuring temperatures of different
samples.

Figure 2.2: The photographs of photothermal detection setups using a thermometer and (A) the
laser diode or (B) the portable laser pointer.
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Chapter 3: Gold Nanoparticle Aggregation-Based Photothermal Biosensor for
Quantitative Genetic Analysis of Pathogens Using a Thermometer

Reproduced in part with permission from the American Chemical Society.
•

Parts of this chapter were published in Analytical Chemistry as a research article
in 2020. (Wan Zhou, Kaiqiang Hu, Sharon Kwee, Liang Tang, Zonghua Wang,
Jianfei Xia, and XiuJun Li. Analytical Chemistry, 2020, 92, 2739-2747.)

•

This chapter introduces a simple, low-cost, and universal quantitative biosensing
platform for genetic analysis using a thermometer.

•

For the first time, gold nanoparticle aggregation-induced photothermal biosensing
mechanism has been applied for quantitative DNA detection.

•

Using Mycobacterium tuberculosis (MTB) as a model pathogen, quantitative
DNA detection can be achieved by simply recording temperature readouts using a
thermometer.

•

This proposed platform provides label-free and DNA amplification-free genetic
analysis, achieving high sensitivity and specificity while avoiding the aid of any
advanced analytical instruments.

•

This method has further developed for the detection of different pathogenic
nucleic acids in addition to MTB, confirming its universality in genetic analysis.
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3.1

Introduction
Quantitative genetic analysis has been applied in many areas, such as food safety and

environmental

surveillance,126

drug

discovery,86

forensic

science,127

and

disease

diagnostics.19,20,87,90 Particularly, quantitative DNA detection methods with high sensitivity and
specificity have become popular in recent years as more featured information can be provided
regarding the target genetics. Currently, various DNA detection techniques have been used
involving colorimetry,128,129 fluorescence,130,131 electrochemistry,132 and chemiluminescence,133
which usually suffer from the essential requirements for expensive and bulky equipment.
Typically, the gold nanoparticles (AuNPs)-based colorimetric bioassays have been the most
commonly used methods for DNA detection, which were attributed to the unique photophysical
property, surface plasmon resonance (SPR) absorption of AuNPs.134,135 By applying AuNP
bioconjugates as a biosensor, distinct color changes can be observed with simple operation and
readouts. However, intrinsic drawbacks have been found, including low or middle detection
sensitivity and unsuitability for quantitative tests unless using specialized instruments, such as
spectrophotometers.
Current DNA detection methods have also relied on a variety of amplification strategies,
such as nucleic acid amplification-based techniques (e.g. polymerase chain reaction (PCR)), and
DNA hybridization-based techniques (e.g. DNA microarray).127,136 Generally, there are two types
of modification are needed. One is to modify AuNPs or other nanomaterials with functional
groups (such as -SH) to get specific binding sites for nucleic acids or DNA probes. The other is
to modify DNA products/primers/probes with functional groups (such as -SH) to bind with
signaling reporters, involving AuNPs, fluorescein amidites (FAM), Cy3, Cy5, Cy7, etc.13,86,90
Both functionalization procedures have led to the increased cost and complexity for bioassays. In
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addition, as the functionalization of nanosensors has always been specifically designed to target
one type of target, a new round of nanomaterial functionalization is required when detecting
different nucleic acid sequences. Such peculiar recognition, amplification, and detection
mechanisms pose limits for versatile broad applications in genetic analysis. Therefore, it is
significant to develop a universal platform integrated with label-free and DNA amplification-free
biosensing mechanisms for quantitative DNA detection at the point of care.
Recently, the nanomaterial-mediate photothermal effect has brought much attention and
been extensively studied in the development of quantitative bioassays, due to the remarkable
photothermal conversion property of photothermal agents.137-139 (The principle of nanomaterialmediated photothermal effects can be referred to Section 1.2, Chapter 1.) Particularly, the
photothermal quantitative immunosensing platform was first established by our group, which
achieved quantitative detection of protein-based cancer biomarkers using a household
thermometer.81 In comparison with conventional immunoassays using colorimetric readouts, like
ELISA,31 the proposed method was advantageous by offering a much simpler quantitative
detection platform at a lower cost. There was no need for costly and bulky analytical instruments
and trained personnel, also with minimal color interference. Unfortunately, most quantitative
biosensing platforms based on nanomaterial-mediated photothermal effects have been developed
for the detection of protein-based biomarkers, whereas there are few photothermal biosensing
platforms for genetic analysis.
In this work, we have herein developed a novel, simple, and universal method for
quantitative genetic analysis using a thermometer, which was on the basis of AuNP aggregationinduced photothermal effects. Basically, there were two competing processes present: the
protection of dispersed AuNPs by single-stranded DNA (ssDNA) probes and the destabilization
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of dispersed AuNPs by salt addition. Upon the addition of target DNA sequences, ssDNA probes
were deprived of the surface protection of AuNPs due to DNA hybridization, which changed the
AuNPs from the dispersed status to the aggregated status. The produced AuNP aggregation was
used as a novel photothermal biosensor generating photothermal heat, which was used to achieve
a quantitative analysis of nucleic acids with a common thermometer by correlating target
concentrations with temperature readouts under the near-infrared (NIR) laser irradiation. This
strategy was superior regarding the procedures and cost because there was no need for DNA
amplification, surface modification of AuNPs, and ssDNA probe modification. There was also
utterly unnecessary to use any bulky and costly instrumentation, and only a thermometer was
used as a signal reader. Moreover, the unmodified AuNPs were applicable to adsorb various
DNA probes, allowing a universal platform for a broad range of genetic targets. As a proof of
concept, Mycobacterium tuberculosis (MTB) was used as a model target pathogen herein, which
is the cause of tuberculosis (TB), one of the deadliest “big 3” infectious diseases, including
human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and
malaria.6 (More information about TB can be referred to Section 4.1, Chapter 4.) The platform
was applied to test Mycobacterium tuberculosis (MTB) DNA, achieving higher sensitivity and
specificity as compared to the colorimetric result obtained from a microplate reader. To the best
of our knowledge, this is the first photothermal DNA biosensing platform using a thermometer
as the signal recorder, and also the first attempt to apply AuNP aggregation in a photothermal
biosensing platform for quantitative genetic analysis.
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3.2

Experimental section

3.2.1 Materials and reagents
All oligonucleotide sequences used in this project were purchased from Integrated DNA
Technologies (Coralville, IA, US) and listed in Table 3.1 as below. Genomic DNA sequences
were extracted from Mycobacterium tuberculosis (M. tuberculosis or MTB), Bordetella pertussis
(B. pertussis), Escherichia coli (E. coli), MCF-7 cells based on previously published
protocols.19,87,140 All the other chemicals and reagents were listed in Section 2.1 (Chapter 2).
Table 3.1: DNA sequences used in the photothermal biosensing platform
DNA
ssDNA probe
MTB target

Sequences (5’-3’)
ATA AAG TTG GTG TTC TGC CCG TTC
GGC GCC TAT CGT GTC GCA CGT GAA GAA CGG GCA
GAA CAC CAA CTT TAT

N. meningitidis probe

AAC CTT GAG CAA TCC ATT TAT CCT GAC GTT CT

N. meningitidis target

AGA ACG TCA GGA TAA ATG GAT TGC TCA AGG TT

miRNA-141 probe

CCA TCT TTA CCA GAC AGT GTT A

miRNA-141 target

UAA CAC UGU CUG GUA AAG AUG G

Giardia lamblia probe

CGT CGA TCA GGC ACG GGC CCT CGT ACC AGG GCA TC

Giardia lamblia target

GAT GCC CTG GTA CGA GGG CCC GTG CCT GAT CGA CG

3.2.2 Procedures of condition optimization
To optimize the concentrations of NaCl in the photothermal biosensing platform,
solutions containing 20 μL of NaCl were prepared in the saline-sodium citrate (SSC) buffers and
added to bare AuNP suspensions (1.2 nM) at the final concentration range from 0 to 100 mM.
Similarly, in the optimization process of ssDNA probe concentration, 20 μL of ssDNA
probes prepared in the SSC buffers were added to bare AuNP suspensions (1.2 nM) with the

39

final concentration varying from 0 to 320 nM, followed by adding the above NaCl solutions (40
mM).
Moreover, to optimize the laser irradiation time, the kinetic temperature increase was
recorded every 30 s from 0 to 10 min under continuous laser irradiation at the power density of
5.2 W/cm2.
All samples were characterized via UV−vis spectra on the microplate reader. The
scanning electron microscope (SEM) images were taken on a Hitachi S5500 scanning
transmission electron microscope. In the photothermal measurement, an 808 nm diode laser was
used to irradiate AuNP suspensions (200 μL) in PCR tubes. Temperature change of each
suspension was recorded using a dual input digital thermometer immediately upon the laser
irradiation for 5 min at the power density of 5.2 W/cm2. The height between the thermometer
probe and the bottom of a detection tube was 0.8 cm in all temperature measurements, avoiding
temperature variations due to varying detection points.
3.2.3 Procedures of quantitative photothermal biosensing using a thermometer
In the photothermal biosensing of target sequences, under the abovementioned optimal
conditions, MTB DNA was added to ssDNA probes protected AuNP suspensions and incubated
at 37 °C for 30 min for DNA hybridization process The concentration range of MTB DNA was
0-1200 nM. After adding the optimal concentration of NaCl solution, the photothermal
measurement of each sample (200 μL) was conducted by recording temperature signals
immediately after laser irradiation at an optimal irradiation time. Detailed information about
photothermal detection using the thermometer can be referred to Section 2.3 (Chapter 2).
To test the specificity of this platform, genomic DNA samples were used instead of MTB
DNA in a similar procedure, which were extracted from M. tuberculosis, B. pertussis, E. coli,
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and MCF-7 breast cancer cells. An extra step was applied before the hybridization step, in which
the genomic DNA samples were first denatured at 95 °C for 10 min, followed by the annealing
step for 1 min.
In the universality tests, three different types of nucleic acid pairs (indicating both probes
and complementary sequences), were used instead of MTB DNA probes and targets, which
referred to Neisseria meningitidis (N. meningitidis), miRNA-141, and Giardia lamblia (G.
lamblia). All concentrations in each pair were 160 nm for probes and 50 nM for complementary
sequences, respectively. The same hybridization and photothermal detection procedures were
performed.
3.3

Results and discussion

3.3.1 Working principle and feasibility tests
The working principle is illustrated in Figure 3.1, which was based on the photothermal
effect of target induced AuNP aggregation. Under the irradiation of a NIR laser, the dispersed
AuNPs have a weak photothermal effect, while aggregated AuNPs have a much stronger
photothermal effect. In the DNA biosensing process, the AuNP aggregation is attributed to the
adsorption disparity onto AuNPs between ssDNA and double-stranded DNA (dsDNA) after
adding high concentrations of salt.141 As previously reported,142 there has been found that the
disparity in adsorption onto unmodified AuNPs exists between ssDNA and dsDNA: The ssDNA
probes are capable to be captured onto AuNPs due to the van der Waals attraction between the
exposed bases and the gold surface; However, dsDNA has little affinity to AuNPs because of its
stable double-helix geometry that inhibits the exposure of nucleobases, which causes
electrostatic repulsive interaction between both negatively charged phosphate backbone and
AuNPs.143-145 On the basis of this principle, unmodified AuNPs are first protected by ssDNA
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probes from salt-induced aggregation in this work. The dispersed status of AuNPs leads to weak
PT effect and low temperature increase upon irradiation of the NIR laser. In the presence of
target DNA, the protection is damaged due to DNA hybridization. The AuNP aggregation is
formed when adding salt and served as a photothermal biosensor. An obvious temperature
increase can be observed when irradiating the aggregated AuNP suspension by the NIR laser. In
the absence of target DNA or when adding non-target DNA, AuNPs remain in dispersed status
while and cause a negligible temperature elevation because of a weak PT effect. As such, by
simply recording the temperature change using a thermometer, DNA quantification can be
achieved in this photothermal biosensing platform.

Figure 3.1: Schematic illustration of the AuNP aggregation-based photothermal DNA biosensing
using a thermometer.
To test the feasibility of this photothermal biosensing strategy, the UV−vis spectra,
photothermal measurement, and SEM images were first investigated in different samples
containing varying components involved in this platform. The results are shown in Figure 3.2.
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Different sample solutions referred to (a) SSC buffer as the blank, (b) bare AuNP suspension, (c)
AuNP suspension upon the addition of NaCl in an SSC buffer, and (d−e) ssDNA probe-protected
AuNP suspensions upon the addition of salt (40 mM) in SSC buffers in the absence (d) and
presence of (e) target DNA (with the concentration of 1600 nM). As seen from the results,
compared to the blank buffer, bare AuNPs remained red color while the typical absorption peak
was 520 nm. The bare AuNPs were in dispersed status with a diameter of 20 nm according to the
SEM image in Figure 3.2C (b). There was no obvious temperature increase obtained under laser
irradiation. However, after adding salt, the color of AuNPs (c) changed to blue and a peak at 750
nm appeared due to red shift of the SPR peak, which was resulted from AuNPs aggregation
(Figure 3.2C (c)). Moreover, around 13 °C of temperature increase was obtained under laser
irradiation. In contrast, when adding ssDNA probes, AuNPs (d) were protected because of the
adsorption of ssDNA on the surface, and no obvious changes were observed in UV-vis spectra,
SEM image, and temperature measurement. In the presence of target DNA, AuNPs (e) were
unprotected and aggregated when adding salt, which was due to the DNA hybridization of
ssDNA probes and target DNA. The color changed from red to purple/blue, and a shoulder peak
centered at around 650 nm appeared in UV-vis spectra, which was mainly due to DNA
hybridization and AuNPs aggregation. The temperature increased obviously around 11 °C under
the laser irradiation for 5 min. Therefore, the feasibility was confirmed when applying target
induced AuNP aggregation for photothermal DNA biosensing using a thermometer based on
temperature signals as readouts.
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Figure 3.2: Feasibility tests of the AuNP aggregation-induced photothermal biosensing. (A) UVvis spectra and (B) temperature changes of different suspensions, including (a) SSC
buffer as blank, (b) dispersed AuNPs suspension (1.2 nM), (c) AuNPs + salt (40
mM) in a SSC buffer, (d) AuNPs + ssDNA (320 nM) + salt (40 mM), and (e)
AuNPs + ssDNA (320 nM) + target DNA (1600 nM) + salt (40 mM). Insets in (B)
are photographs of suspension (a-e) (from left to right). (C) SEM images of
different suspensions of (b) to (e). The power density of the 808 nm NIR laser was
5.2 W/cm2, and the irradiation time was 5 min. Error bars represent standard
deviations (n = 3).
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3.3.2 Condition optimization
As different experimental conditions can significantly affect the detection performance,
we, therefore, optimized different conditions, including salt (NaCl) concentrations, ssDNA probe
concentrations, and laser irradiation time in the following experiments. Particularly, absorbances
at 520 nm from the UV-Vis spectra were used to study the AuNPs dispersed status, while
absorbance at 800 nm was chosen to study the photothermal effect of aggregated AuNPs under
NIR laser irradiation.
First, the concentration of salt (NaCl) was optimized because it was the key component to
cause AuNP aggregation, which had a strong PT effect. Different concentrations of NaCl were
added to AuNPs suspensions in the final concentration range of 0-100 mM. The samples were
characterized by UV-vis spectroscopy, photothermal measurement, and SEM. The results are
shown in Figure 3.3. When increasing the salt concentration, the color of AuNPs suspensions
changed from red to purple/blue, indicating changes in the surface charge of AuNPs which led to
the aggregation.141,146,147 This phenomenon was further proved by UV-vis characterization, in
which a new peak at a longer wavelength around 750 nm appeared, in addition to the one at 520
nm when increasing the salt concentration This was due to the formation of AuNP aggregates,
which had stronger photothermal effects in the NIR range. In addition, the absorbances at 520
nm decreased sharply at the salt concentrations of 0-40 mM owing to the depletion of dispersed
nanoparticles, and then reached a plateau when the concentration was higher than 40 mM due to
the complete formation of aggregated nanoparticles. Conversely, absorbances at 800 nm
increased when increasing the salt concentrations from 0 to 40 mM and reached a plateau at
concentrations higher than 40 mM and up to 100 mM. These results were consistent with the
SEM image, showing the aggregated status of AuNPs at the concentration of 40 mM NaCl. The
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absorbances at 800 nm further proved the formation of aggregated AuNPs when the
concentration of NaCl increased. Upon the NIR laser irradiation, the temperature first increased
rapidly upon adding salt in the concentration range from 0-40 mM, then reached a plateau (ΔT
~18 °C) in the concentration range of 40-65 mM, and slightly decreased afterward. This result
can be explained that more aggregated AuNPs formed when adding salt to bare AuNPs
suspensions. However, when adding excess salt (higher than 40 mM), the aggregated AuNPs
accumulated and started to precipitate, leading to lower signals in both absorbances at 800 nm
and temperature measurement. Therefore, 40 mM of salt was selected as the optimal
concentration and used in the following experiments.
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Figure 3.3: Optimization of salt concentrations in the AuNP aggregation-induced photothermal
biosensing method. (A) UV-vis spectra, (B) Absorbances at 520 nm and 800 nm,
and (C) Photographs of AuNPs suspensions upon the addition of salt with the final
concentration ranging from 0-100 mM. The inset in (C) is the SEM image of
AuNPs suspension after the addition of 40 mM salt. (D) Temperature increases of
the above AuNPs suspensions under 808 nm laser irradiation. The laser power
density was 5.2 W/cm2 and the irradiation time was 5 min. SSC buffer was used as
blank. Error bars represent standard deviations (n = 3).
Moreover, the ssDNA probe concentration was also optimized in order to obtain the best
protection performance of AuNPs. Different concentrations of ssDNA probes in the range of 0320 nM were added to AuNPs suspensions, followed by the addition of 40 mM NaCl. Figure 3.4
shows the UV-vis spectra, photographs, SEM image, and temperature measurement of the above
suspensions. It can be seen that the suspensions changed from purple/blue to red color with the
increase of ssDNA probe concentrations, representing the changes of surface charges and the
status of nanoparticles. The absorption peak at a longer wavelength around 750 nm became
weaker until it disappeared when adding higher concentrations of ssDNA probes, indicating the
depletion of aggregated AuNPs and better ssDNA protection. Additionally, the absorbances at
520 nm increased gradually in the concentration range from 0-160 nM, implying the formation
of dispersed AuNPs due to the increased protection property of AuNPs by ssDNA probes. No
obvious change on UV-vis absorbances at both wavelengths (520 and 800 nm) was observed as
compared to bare AuNPs, when the concentration was higher than 160 nM, indicating that the
maximum protection of AuNPs can be achieved at the ssDNA concentration of 160 nM.
Moreover, the absorbance at 520 nm reached the highest value at 160 nM, which was almost the
same as the bare AuNPs, suggesting that the dispersed status of nanoparticles was recovered
from salt-induced aggregation by the protection of ssDNA probes. This phenomenon was further
verified in the SEM image, showing dispersed AuNPs. In contrast, absorbances at 800 nm
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decreased when increasing the ssDNA probe concentrations from 0 to 160 nM and reached the
lowest value at 160 nM, indicating the depletion of aggregated nanoparticles as well as weaker
PT effects. Upon the NIR laser irradiation, the temperature increased dramatically up to ΔT of
~18 °C when no ssDNA probes were added, owing to the strong PT effect of AuNP aggregation.
When adding ssDNA probes, temperature signals decreased and reached a plateau (ΔT of ~6 °C)
at the final concentration of 160 nM, similar to bare AuNPs. This result proved that AuNPs were
protected by the addition of ssDNA probes and the weaker PT effects of the dispersed AuNPs.
Conclusively, more AuNPs remained in the dispersed status in the suspension when increasing
the ssDNA probe concentration, and finally reached the initial bare AuNPs status. Therefore, 160
nM was selected as the optimal concentration for ssDNA probes and used in the following
experiments.
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Figure 3.4: Optimization of ssDNA concentrations in the AuNPs aggregation-based
photothermal biosensing method. (A) UV-vis spectra, (B) absorbances at 520 nm
and 800 nm, and (C) photographs of AuNPs suspensions with ssDNA protection in
the final concentration range of 0-320 nM in the presence of 40 mM salt. The inset
in (C) is the SEM image of the ssDNA (160 nM) protected AuNPs suspension in
the presence of 40 mM salt. (D) Temperature increases of the above AuNPs
suspensions under the 808 nm laser irradiation. The laser power density was 5.2
W/cm2 and the irradiation time was 5 min. Error bars represent standard deviations
(n = 3).
As the irradiation time has a remarkable influence on the temperature measurement, it
was also optimized in the AuNPs aggregation-based photothermal biosensing platform. With
optimal concentrations of ssDNA probes and NaCl, the kinetic temperature increases of different
suspensions were recorded every 30 s from 0-10 min, including SSC buffer as blank, bare
AuNPs suspension, salt-induced aggregated AuNPs suspension, and ssDNA (160 nM) protected
AuNPs suspension. The results are shown in Figure 3.5. Under the continuous laser irradiation,
the temperature of the aggregated AuNPs suspension increased dramatically in the first 2.5 min,
then exhibited a stagnant increase, and finally reached the plateau (ΔT of ~14 °C) at
approximately 8 min, where the heat balance was achieved between heat generation from the
photothermal effect and heat dissipation to the environment. However, only a slight temperature
increase of ~2 °C was recorded from the SSC buffer, while a temperature increase of ~4 °C
occurred to bare AuNPs and ssDNA probes protected AuNPs in the presence of salt. Therefore,
to acquire a stable and sensitive temperature measurement, 8 min was selected as the optimal
laser irradiation time and used in the following experiments.
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Figure 3.5: Optimization of the irradiation time in the photothermal biosensing method.
Temperature increases versus irradiation time in the range of 0-600 s under the laser
irradiation from different suspensions: SSC buffer as blank, AuNPs suspension,
aggregated AuNPs + salt, and AuNPs + ssDNA + salt (under optimal
concentrations of salt and ssDNA probes). The laser power density was 5.2 W/cm2.
3.3.3 Photothermal quantitative DNA biosensing using a thermometer
Under optimal conditions, target DNA samples were quantitatively detected in this
photothermal biosensing platform by simply monitoring the temperature changes using a
thermometer. In this work, MTB DNA was used as a model target to test this platform as a proof
of concept. Mycobacterium tuberculosis (MTB) is the main bacillus causing tuberculosis (TB),
which was recognized as one of the deadliest “big 3” infectious diseases. TB has led to around
1.5 million deaths annually and is a threat to public health particularly in low-income
countries.148 Currently, there are various detection techniques developed for MTB DNA, such as
colorimetry, electrochemistry, fluorescence, and chemiluminescence.149-153 Nevertheless, most of
these methods require sophisticated infrastructure and well-trained personnel, which also rely on
complicated DNA amplification procedures. These limitations significantly lead to the high cost
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of TB diagnosis and limit the wide accessibility in low-resource settings. In this work, we
applied this novel platform for quantitative detection of MTB DNA to demonstrate the
application of the AuNP aggregation-based photothermal biosensing in genetic analysis using a
common thermometer, with no need for DNA amplification or expensive instruments.
This platform was first studied and characterized for quantitative DNA biosensing via
UV-vis spectroscopy using a microplate reader. Under optimal conditions, different
concentrations of target MTB DNA (0-1200 nM) were added to ssDNA probes protected AuNPs
suspensions, followed by the addition of NaCl. The results in colorimetric assays are
summarized in Figure 3.6. It can be found that with the addition of target DNA, a shoulder peak
at around 650 nm to the NIR range appeared, and increased with the increase of MTB DNA
concentrations, while absorbances at 520 nm decreased. This result can be explained that more
ssDNA probes were consumed and hybridized with the target DNA, and the protection to AuNPs
was impaired. Upon the addition of NaCl, more AuNPs aggregated, and the color of samples
changed from red to purple/blue. Moreover, the absorbances at 650 nm were proportional to the
target concentration with a linear relationship obtained in the concentration range from 4 to 1200
nM. These results indicated that quantitative bioanalysis was obtained for DNA detection using
the AuNP aggregation-induced biosensing platform. Accordingly, the limit of detection (LOD)
was calculated based on three folds standard deviation above the blank (the S/N ratio of 3) and
determined to be 2.0 nM, whereas the colorimetric detection requires a spectrophotometer (like
the microplate reader).
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Figure 3.6: UV-vis characterization of the photothermal biosensing system for quantitative
genetic analysis and colorimetric detection of MTB DNA using a microplate reader.
(A) UV-vis spectra and (B) calibration curve of absorbance at 650 nm with
photographs (inset) of target DNA-induced AuNPs aggregation suspensions upon
the addition of target DNA with different concentrations of 0, 4, 60, 400, 800, 1200
nM (from left to right). Error bars represent standard deviations (n = 3).
This photothermal biosensing platform was then applied for the quantitative detection of
MTB DNA based on temperature readouts using a thermometer. The above suspensions were
irradiated by a NIR laser (808 nm) at different concentrations of the target MTB DNA. The
temperature was recorded immediately after 8 min using a digital thermometer. The results in
Figure 3.7 exhibit that the temperature raised when increasing the target DNA concentration. A
linear relationship was obtained between the temperature increase with the logarithmic
concentration of target MTB DNA. The detection range was 2-1200 nM, with a squared
correlation coefficient of 0.996. The LOD was 0.28 nM based on the S/N ratio of 3, which
proved about 10-fold higher sensitivity than that obtained from the abovementioned colorimetric
detection method. Besides, in comparison with conventional colorimetric methods, the proposed
photothermal biosensing platform is much simpler, cheaper, and more convenient for
quantitative analysis, because only an inexpensive thermometer was needed as a signal reader.
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However, expensive spectrophotometers are required in conventional colorimetric methods for
sensitive and quantitative analysis. The sensitivity is even higher in this photothermal biosensing
platform compared to the previously reported results (e.g. reported LODs: 2.5 nM,154 2.6 nM,155
10.4 nM,156 and 33 nM,157). Furthermore, the detection could be completed within 40 min, and
no DNA amplification and any analytical instrumentation were needed, greatly decreasing the
detection time, complexity, and cost of the entire biosensing assay.

Figure 3.7: Quantitative genetic analysis of MTB on the AuNP aggregation-based photothermal
biosensing platform using a thermometer. Calibration curve of temperature
increases versus target MTB DNA logarithmic concentrations in the range of 21200 nM. The laser power density was 5.2 W/cm2, and the irradiation time was 8
min. Error bars represent standard deviations (n = 3).
3.3.4 Specificity tests
As an important factor in DNA bioassays, the specificity of this photothermal biosensing
platform was also investigated. The M. tuberculosis genomic DNA was used as a target in the
assay, while various types of nucleic acids were used as interfering substances at 3-fold higher
concentrations, including genomic DNA sequences extracted from B. pertussis, E. coli, and
breast cancer cells (MCF-7), along with cancer-associated miRNA (miRNA-141) and parasitic
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infections-related G. lamblia DNA. UV-vis characterization using absorbances at 650 nm and
photothermal biosensing using temperature as readouts were studied and the results are shown in
Figure 3.8. In the presence of the target M. tuberculosis DNA, an obvious absorbance at 650 nm
appeared with a dramatic temperature increase of ~9 °C. However, in the presence of non-target
sequences, like ssDNA, B. pertussis, E. coli, MCF-7 genomic DNA, miRNA-141, and G.
lamblia DNA, there was no apparent temperature change as compared to the SSC buffer as
blank. It was noted that when detecting target M. tuberculosis genomic DNA even at a 3-fold
lower concentration than other nucleic acids, there was more than 200% higher temperature
increase observed. These results confirmed the high specificity of the photothermal biosensing
platform for quantitative genetic analysis even in the presence of higher concentrations of
interfering substances.
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Figure 3.8: Specificity tests using different interfering nucleic acids on the photothermal
biosensing platform. (A) Absorbances at 650 nm and (B) temperature increases
upon the addition of M. tuberculosis target genomic DNA (39 nM) versus different
interfering substances at 3-fold higher concentrations including SSC buffer as
blank, ssDNA, genomic DNA extracted from B. pertussis, E. coli, and MCF-7 cells,
miRNA-141, and G. lamblia DNA. The laser (808 nm) power density was 5.2
W/cm2, and the irradiation time was 8 min. Error bars represent standard deviations
(n = 3).
3.3.5 Universality tests
In order to explore the possibility of the proposed photothermal biosensing platform for
more versatile applications, the universality in the genetic analysis was further investigated.
Different kinds of nucleic acids were employed in this platform, including N. meningitidis DNA,
miRNA-141, and G. lamblia DNA. For each test, a pair of nucleic acid probes and their
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complementary targets were used in the photothermal measurement. As seen in Figure 3.9, there
were distinctive increases of temperature (over 10 °C) obtained in all tests compared with the
control signal with varying target nucleic acids, which suggested that this presented method can
be used as a universal platform for versatile and wide applications in the biosensing of nucleic
acids.

Figure 3.9: Detection of various target nucleic acids (N. Meningitidis DNA, miRNA-141, and G.
lamblia DNA) using the photothermal biosensing platform. All tests were
performed under optimal conditions with all complementary probes and targets at
the same concentrations of 160 nM and 50 nM, respectively. Error bars represent
standard deviations (n = 3).
3.3.6 Analytical recovery
The analytical recoveries were also studied to evaluate the analytical performance of this
photothermal biosensing platform. In these tests, M. tuberculosis genomic DNA was used as the
target and spiked in different media with varying concentrations. The results are shown in Figure
3.10, including color images and temperature increases of different samples upon the laser
irradiation for 8 min. The analytical recoveries of different spiked samples (Sample No.1-3) were
calculated comparing spiked concentrations (13 nM to 39 nM, or 2.5 µg/mL to 7.5 µg/mL) and
detected concentrations (2.4 µg/mL to 8.3 µg/mL). The analytical recoveries were obtained from
94.5%-110.2% when testing spiked samples in SSC buffer, which were within the acceptable
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recovery range for the validation of bioanalytical methods.158 Additionally, this platform was
also challenged by directly spiking target DNA in a 50% normal human serum sample (Sample
No. 4), although genetic assays usually require cell lysis and DNA extraction before DNA
hybridization.159,160 The analytical recovery of 91.5% was acquired and acceptable, further
demonstrating the excellent analytical performance of this platform even testing samples in a
complex matrix. Besides, the photothermal biosensing based on target induced AuNP
aggregation provided a simple yet reliable platform for the quantitative detection of nucleic
acids, when comparing to color changes observed by the naked eye.

Figure 3.10: Analytical recoveries when testing M. tuberculosis genomic DNA in different media
at varying spiked concentrations using the photothermal biosensing platform. Insets
are photographs of different spiked samples. The laser power density was 5.2
W/cm2, and the irradiation time was 8 min. Three parallel experiments were
conducted in each test.
3.4
Summary
In this work, for the first time, a simple yet versatile photothermal biosensing platform
was developed based on target induced AuNP aggregation and applied for sensitive and
quantitative detection of nucleic acids using a thermometer. Only an inexpensive thermometer
was needed as the signal reader in this bioassay, with no assistance from any specialized and
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costly analytical instrumentation. As a low-cost detection method, high sensitivity was achieved,
which was nearly 10-fold higher than the colorimetric result obtained from a spectrophotometer.
This research also confirms the universality of this platform for DNA detection, as labeling of
DNA probes, AuNPs, or DNA amplification processes are not required, which greatly reduces
the complexity and cost of detection assays. Furthermore, this photothermal biosensing platform
also provides the unprecedented potential for the quantitative detection of a wide range of
biochemicals and biological organisms, not solely nucleic acids. For instance, when employing
aptamers as probes, this platform can be further applied to detect a variety of chemicals such as
protein biomarkers,161 cancer cells,162 microorganisms,136 and metal ions (like Hg2+).163,164 Given
more and more inexpensive portable yet powerful NIR laser pointers become commercially
available, this novel biosensing method will bring new possibilities to conventional detection
methods, particularly for point-of-care testing.
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Chapter 4: Low-Cost Quantitative Photothermal Genetic Detection of MTB on a Paper
Hybrid Microfluidic Device Using a Thermometer

Reproduced in part with permission from the American Chemical Society.
•

Parts of this chapter were published in Analytical Chemistry as research articles in
2020. (Wan Zhou, Mengli Feng, Alejandra Valadez, and XiuJun Li. Analytical
Chemistry, 2020, 92, 7045-7053. Wan Zhou, Jianjun Sun and XiuJun Li.
Analytical Chemistry, 2020, 92, 14830-14837.)

•

This chapter introduces a simple, low-cost, and miniaturized quantitative
biosensing platform for genetic analysis using a thermometer.

•

For the first time, the photothermal biosensing strategy was accomplished on a
paper hybrid microfluidic device for quantitative detection of a model pathogenic
target, Mycobacterium tuberculosis (MTB) DNA.

•

Only a thermometer is needed in the quantitative detection process, with no need
for any costly analytical instruments.

•

This proposed platform provides higher sensitivity than conventional colorimetric
methods for detecting MTB DNA while eliminating the issues of color
interference.

•

In comparison with Chapter 3, this method has significant improvements on the
aspects of reagent/sample consumption, the photothermal biosensing time, and the
bioassay cost.
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4.1

Introduction
Pathogenic microorganisms cause different infectious diseases, leading to a high burden

on public health globally. Tuberculosis (TB) remains the leading cause of a single infectious
agent, resulting in around 1.5 million deaths annually, which is commonly caused by the bacillus
Mycobacterium tuberculosis (MTB).6 (More information about TB can be referred to Section 3.1,
Chapter 3.) In the United States, TB cases have been reported in all states with an average
national incidence rate of 2.8 cases per 100,000 persons.165 TB typically affects the lungs, which
is known as the pulmonary TB, while other sites could also be attacked by TB bacteria, such as
the pleura, genitourinary tract, spine, and brain, causing the extrapulmonary TB.166 There are two
types of illness, the latent TB and the active TB, while a person with the former one has no
symptoms, and the TB bacteria cannot spread. However, the TB bacteria carried by the latent TB
patients can be activated, spread, and cause disease due to the patients’ sickness (e.g. diabetes),
stress, aging, smoking, and alcohol consumption, etc. Therefore, early diagnosis of both latent
and active TB is clinically important. Latent TB usually happens at an early stage of infection,
where MTB is internalized into the phagosomes of host macrophages and exhibits latency.167-169
However, the latent TB becomes active when MTB starts to replicate after rupturing the
phagosomal membranes and translocating into the cytosol.167-169 Recently, two types of genes
(EsxA and EsxB) and their encoding secreted proteins (6-kDa early secreted antigenic target or
ESAT-6, and 10-kDa culture filtrate protein or CFP-10) have been found to play a vital role in
the transition from latent TB to active TB;167-171 therefore these genes can be used as specific
targets for MTB DNA detection.
Current diagnostic methods for TB disease mainly include sputum smear microscopy,
culture-based methods, and rapid molecular tests. The sputum smear microscopy technique was
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developed more than a century ago and has been applied to determine the presence of bacteria in
sputum samples using a microscope. In the worldwide regions, over 90% of TB cases from
people living in low- and middle-income countries have been diagnosed by using sputum smear
microscopy as well as chest radiology. However, a low rate (e.g. 28% in 2009, reported by
WHO) of sputum smear-positive results was notified as compared with the total TB cases.172 The
culture-based methods, as the current reference standard, have been relied on advanced
laboratory instrumentation, in which the results are generally provided up to 12 weeks.
Molecular tests have undergone rapid development for laboratory diagnostics for TB infection in
the recent decade. One typical example is the Xpert○R MTB/RIF (Cepheid, US) assay, which has
been developed as a great advance over these above two methods and recommended for TB
diagnosis by WHO since 2010. This test has utilized the real-time PCR (rt-PCR) technology to
diagnose TB from unprocessed clinical specimens. The assay could be conducted on an
automated cartridge-based system and provide results within 2 hours with better accuracy than
sputum smear microscopy. Nevertheless, there is still a major issue in promoting molecular
diagnostics, especially in developing countries, namely the high cost of the instrument. For
instance, the instrument generally costs nearly $20,000 with each disposal cartridge around
$10.173 Therefore, there is still in great demand for developing simple yet low-cost molecular
tests to detect MTB DNA for the diagnosis of TB, especially for the subclinical infection.148,174
Various detection methods targeting MTB DNA have been extensively studied based on
different biosensing technologies, such as colorimetry,149,150 electrochemistry,151 fluorescence,152
and chemiluminescence.153. For example, an electrochemical DNA biosensor designed for MTB
DNA was developed to detect the PCR amplified products via DNA hybridization assays.175
With signal amplification, this method was validated by testing target DNA in clinical samples
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and provided high specificity and sensitivity. Nonetheless, similar as the Xpert○R MTB/RIF assay,
most methods require complicated DNA amplification procedures (PCR,176,177 LAMP,178,179
etc.), sophisticated infrastructure, and well-trained personnel, which still significantly lead to the
high cost of detection assay, thus limiting their accessibility in low resource settings.
Nanomaterial-mediated photothermal biosensing methods have recently attracted much
attention in the quantitative detection of biomolecules. (The principle of nanomaterial-mediated
photothermal effects can be referred to Section 1.2, Chapter 1.) Several benefits have been
drawn, such as the simplicity, low cost, and great convenience in the temperature-based signal
recording using a thermometer. For example, several photothermal biosensing platforms for the
detection of biomolecules have been developed by our lab and other researchers.36,42,81-83,180,181
The traditional immunosensing signals were converted to photothermal signals (temperature),
and biomolecules were quantified by only using a common thermometer as a signal recorder. For
instance, we developed the first photothermal biosensing method using a common thermometer
for quantitative cancer biomarker detection.81 Unfortunately, most of the current photothermal
biosensing strategies have focused on the detection of proteins, and there have been very few
reports about nucleic acid analysis.
As a promising point-of-care (POC) diagnostic tool, microfluidic lab-on-a-chip (LOC)
technology has been commonly used for the diagnosis of various diseases, due to the enormous
benefits of miniaturization, portability, and low reagent consumption.19,125,130 (The evolution of
microfluidic devices has been discussed in Section 1.3, Chapter 1.) Paper-based microfluidic
devices have been particularly attractive among LOC devices, given the merits of paper
substrates such as the extremely low cost, ease of manipulation, and 3D porous microstructure
with a high surface-to-volume ratio.20,111 For example, a low-cost paper-based device was
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developed in our lab for genetic analysis via a one-step surface modification method using 3aminopropyl trimethoxysilane (APTMS).111 The nonfunctionalized DNA probes were directly
immobilized on paper through ionic interaction between the negatively charged DNA probes and
positively charged paper surface (Figure 4.1). Enhanced DNA immobilization efficiency and
detection sensitivity were obtained using a paper substrate for the detection of fluorescencelabelled nucleic acids (Cy3-target DNA). However, using paper as a substate material in
fabricating microfluidic chips, some drawbacks exist like the poor performance of liquid
controlling and low resistance to organic solvents. To solve these issues, our lab has developed
paper/polymer hybrid microfluidic devices by integrating paper with rigid polymers for POC
diagnostics.31,85,90,130 These obtained hybrid devices have been capable to meet assorted
requirements for sample immobilization, fluid processing, and signal analyzing. However, this
paper/polymer hybrid microfluidic platform has not been integrated with photothermal
biosensing for quantitative DNA detection.

Figure 4.1: Scheme illustration of a one-step surface modification method for grafting DNA
codes on paper substrates based on ionic adsorption, enabling a simple, rapid,
versatile, and low-cost application of pathogen detection.
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Herein, we developed a simple, low-cost, and quantitative DNA detection method on a
paper/polymer hybrid device based on AuNP-mediated photothermal effects.182 The capture
probes were first immobilized on APTMS-modified paper after one-step surface modification. In
the presence of the target MTB DNA, sandwich hybridization occurred on paper, introducing
DNA probe-functionalized gold nanoparticles (AuNPs) onto the hybrid device. The captured
AuNPs were used as a catalyst in the catalytical oxidation reaction of the substrate TMB
(3,3’,5,5’-tetramethylbenzidine). The obtained oxidized TMB (ox-TMB) was served as a strong
photothermal reagent,42 and converted the DNA concentration information to temperature signals
under the near-infrared (NIR) laser irradiation. Therefore, the target DNA was quantitatively
detected by using only a thermometer as the signal reader for the tuberculosis diagnosis. The
quantification of target DNA was achieved by only using a thermometer in the on-chip
temperature measurement. This is the first report to integrate the photothermal biosensing
strategy on a paper hybrid microfluidic device, enabling a simple and low-cost method for
quantitative detection of DNA. Compared to conventional colorimetric methods, this method has
provided higher sensitivity with no issues of color interference, while there is no need for
advanced analytical instruments.
4.2

Experimental section

4.2.1 Materials and reagents
All chemicals and reagents involved in this work were listed in Section 2.1 (Chapter 2).
All synthetic oligonucleotide sequences used in this work were received from Integrated DNA
Technologies (Coralville, IA, US) and listed in Table 4.1. The genomic nucleic acid species were
kindly provided by Prof. Jianjun Sun’s lab (UTEP), including Mycobacterium tuberculosis
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(MTB, belongs to the MTB EsxA gene), Mycobacterium smegmatis (M. smegmatis),
Mycobacterium marinum (M. marinum), and TB knockout (the MTB strain with deletion of
EsxB:EsxA operon). The concentrations of DNA samples were determined via a NanoDrop
spectrophotometer (Sigma-Aldrich, St. Louis, MO, USA).
UV-vis characterization was performed on a microplate reader (Molecular Devices, LLC,
Sunnyvale, CA, US). The 808 nm diode laser (Model MDL-III-808, Opto Engine, Midvale, UT,
US) and a digital thermometer (Model 421502, Extech Instruments Corporation, US) were used
in photothermal biosensing.
Table 4.1: DNA sequences used in this work
DNA

Sequences (5’-3’)

Capture probe

ATA AAG TTG GTG TTC TGC CCG TTC

Detector probe

TTC ACG TGC GAC ACG ATA GGC GCC (A)15 SH
GGC GCC TAT CGT GTC GCA CGT GAA GAA

Synthetic MTB target
CGG GCA GAA CAC CAA CTT TAT
4.2.2 Preparation of DNA-AuNPs conjugates
The DNA-AuNPs conjugates were freshly synthesized based on a modified
protocol.183,184 The thiolated DNA probes (100 μM) were added into a TCEP aqueous solution
(100 μM) in a volume ratio of 1:2 and incubated at room temperature for 0.5 h. The AuNPs
suspensions (1.2 nM, 1.0 mL) were added to the above mixture, followed by incubation
overnight. Then 120 μL of 1% SDS and 12 μL of NaCl (2.0 M) were added to the suspension
dropwise and allowed to incubate for a day. The obtained suspension was centrifuged at 13,000
rpm for 20 min, followed by washing three times. The acquired pellet was redispersed in 0.1%
SDS PBS buffer (10 mM, pH 7.4, 150 mM NaCl) and kept in the fridge (4 °C). The newly
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synthesized DNA probe-AuNP conjugates were characterized using absorbances via UV-vis
spectroscopy.
4.2.3 Fabrication of the paper/PMMA hybrid microfluidic device
The paper/PMMA hybrid microfluidic device was first designed via the Adobe AI
software, following our published work,31,90 which mainly consisted of paper-based
incubation/detection reservoirs and a PMMA base as shown in Figure 4.2. Briefly, PMMA sheets
were laser ablated using a laser cutter (Epilog laser, Golden, CO, USA), creating 6 reservoirs
(3.5 mm in diameter and 1.5 mm in depth). The chromatography paper was also cut on the laser
cutter to form circular disks (3.5 mm in diameter) and then inserted into the PMMA reservoirs.
The whole size of the obtained paper/PMMA hybrid device was 75 mm x 18 mm.

Figure 4.2: Design and assembly of the paper/PMMA hybrid microfluidic device.
4.2.4 On-chip DNA hybridization procedures
Prior to the on-chip DNA hybridization process. a one-step surface modification method
was used to modify paper substrate for DNA probe immobilization based on a previously
published protocol from our group.111 Each paper reservoir was treated with APTMS (10 µL,
5%, v/v) for 10 min, and then dried under ambient temperature. DNA capture probes (5 µL, 1
µM) were added to each APTMS-modified paper reservoir and incubated for 0.5 h at 37 °C.
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BSA solution (3%, w/v) was then added as the blocking reagent and incubated for 10 min at 37
°C. The DNA probe-AuNP conjugates and target MTB DNA with varying concentrations were
mixed in a volume ratio of 1:1 and prehybridized for 0.5 h at 37 °C. The obtained mixture was
added to the device with 10 µL per reservoir and incubated for 0.5 h at 37 °C. Note that washing
steps were performed after each step to remove the nonspecific binding and residues.
Additionally, when using genomic DNA, the samples were firstly denatured at 95 °C for 5 min
and then annealed on ice for 1 min before the prehybridization step.
4.2.5 On-chip photothermal biosensing of MTB DNA
After DNA hybridization, a mixture containing TMB (0.25 mg/mL), H2O2 (1.25 M), and
the citrate buffer, was added to the hybrid device with 20 µL per reservoir, followed by reaction

for 20 min under ambient conditions. Each reservoir was then irradiated by the 808 nm laser with
a power density of was 0.16 W/mm2. On-chip temperature measurement was performed using a
thermometer immediately after irradiation. Detailed information about photothermal detection
using the thermometer can be referred to Section 2.3 (Chapter 2).
4.3

Results and discussion

4.3.1 Working principle and feasibility tests
The on-chip genetic analysis is based on DNA immobilization on paper substrate. A onestep surface modification method has been developed by our group to modify paper substrate and
immobilize DNA probes.111 Briefly, by using APTMS, the amine groups are introduced onto the
cellulose paper surface via a one-step condensation reaction between APTMS and hydroxyl
groups on the paper surface. As such, nonfunctionalized DNA probes can be simply immobilized
on APTMS-modified paper via ionic adsorption between the positively charged paper surface
and negatively charged DNA probes. Compared to conventional glass surface modification
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methods for DNA immobilization, the proposed method is advantageous due to its simple,
versatile, low cost, and time-saving process, which has been applied for simple and convenient
DNA probe immobilization herein.
As shown in Figure 4.3, the working principle for the photothermal detection of MTB
DNA on a paper hybrid device is based on AuNP-mediated photothermal effects. Firstly, DNA
capture probes are immobilized on the paper substrate after one-step surface modification using
APTMS.111 In the presence of target DNA, the sandwich hybridization occurs among capture
probes, target DNA, and AuNPs-labeled detector probes, after which the AuNPs are then
introduced on paper. When adding the chromogenic substrate TMB on the hybrid device, AuNPs
are used in the catalytical oxidization reaction of TMB, producing the ox-TMB with an obvious
color change from colorless to blue. Moreover, the product ox-TMB as a strong NIR
photothermal agent can be used to generate heat under NIR laser irradiation, due to efficiently
photothermal conversion from photon energy to thermal energy.42 As such, the temperature
increases and can be recorded using a thermometer upon the irradiation of an 808 nm laser.
When the concentration of target DNA increases, more AuNPs are introduced on the paper
hybrid chip, and more ox-TMB with a darker blue color is produced, leading to increasing
temperature signals. As a result, the temperature signals are correlated with the target
concentrations. The quantitative detection of target MTB DNA is achieved on the paper hybrid
device using a thermometer based on the photothermal biosensing strategy.
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Figure 4.3: Schematic illustration of the working principle for the AuNP-mediated photothermal
biosensing of MTB target DNA on a paper hybrid device using a thermometer.
The feasibility of the AuNP-mediated photothermal biosensing strategy was first studied,
and the results are shown in Figure 4.4. Different samples (a-g) were prepared and characterized
via UV-vis spectroscopy, containing various combinations of three components (TMB, H2O2,
and AuNPs) from the AuNP-catalyzed TMB oxidization reaction system. Only sample (g)
containing all three components showed a clear blue color and an absorption peak at around 650
nm, while there was no obvious change in the photographs and UV-vis spectra for other samples.
The result confirmed the formation of the oxidized product, ox-TMB with the characteristic
absorption peak.42 In comparison with samples (d) and (g), it also proved that AuNPs had the
peroxidase-mimicking property and were used to facilitate the oxidization reaction of TMB in
the presence of H2O2. Besides, a temperature increase of nearly 15 °C was observed in the
sample (g) under the irradiation of the 808 nm laser, which was attributed to the strong
photothermal conversion of the ox-TMB in the NIR region. Whereas there were negligible
temperature elevations recorded in other samples, indicating that there was little interference
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from other components, and temperature increases were only derived from the ox-TMB
production. Therefore, the feasibility was confirmed for the AuNP-mediated photothermal
detection method.

Figure 4.4: Feasibility tests of the AuNP-mediated photothermal biosensing method. (A) UV-vis
spectra and (B) temperature increases of different components in the AuNPcatalyzed TMB oxidization reaction system, including the citrate buffer as blank,
(a) TMB, (b) H2O2, (c) AuNPs, (d) TMB + H2O2, (e) AuNPs + H2O2, (f) TMB +
AuNPs, and (g) AuNPs + TMB + H2O2. Insets are photographs of the above
samples. The laser power density was 0.16 W/mm2, and the irradiation time was 5
min. Error bars indicate standard deviations (n = 6).
4.3.2 Condition optimization
To obtain the maximum amount of photothermal biosensor (ox-TMB) and best detection
performance, the concentration of TMB was first optimized in this nanomaterial-mediated
photothermal biosensing platform. Given a constant concentration of AuNPs (0.8 nM) and the
reaction time (20 min), different TMB concentrations in the range from 0 to 1.5 mg/mL were
tested. The off-chip UV-vis spectroscopy and on-chip temperature measurement were used to
characterize the optimization process. It was noted that the absorbance at 650 nm was selected to
represent the characteristic peak of ox-TMB production, and the absorbance at 810 nm was
selected to represent the typical absorption in the NIR region. As results are shown in Figure 4.5,
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the absorbances at 650 nm increased in the concentration range of 0-0.25 mg/mL and decreased
at higher concentrations. The results indicated that, given a constant amount of catalysts, the
production of ox-TMB was accumulated when increasing TMB concentrations and reached the
maximum amount at the concentration of 0.25 mg/mL. When adding excessive amounts of
TMB, a slight decrease of absorbances at 650 nm was observed, which might be attributed to the
formation of a light-yellow colored product because of further oxidization.185,186 Similar changes
were found in the absorbances at 810 nm achieving the maximum absorption obtained at 0.25
mg/mL, suggesting the strongest NIR photothermal absorption. Upon the irradiation of the NIR
laser, the temperature increased from ΔT ~2 to 12 °C in the TMB concentration range of 0-0.25
mg/mL and reached a plateau (ΔT ~12°C) afterward, indicating the maximum signals obtained at
0.25 mg/mL. Therefore, 0.25 mg/mL was used as the optimal TMB concentration in the
following experiments.
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Figure 4.5: TMB concentration optimization in the AuNP-catalyzed TMB oxidization reaction
system. (A) UV-vis spectra, (B) absorbances at 650 nm and 810 nm, and (C) onchip temperature measurement of reaction solutions with different TMB
concentrations. The laser power density was 0.16 W/mm2, and the irradiation time
was 5 min. Error bars indicate standard deviations (n = 3).
Similarly, the concentration of AuNPs (as the catalyst) was also optimized to obtain the
maximum amount of ox-TMB and best photothermal biosensing performance in this TMB
oxidization reaction system. Different concentrations of AuNPs in the range of 0-1.2 nM were
tested under the optimal concentration (0.25 mg/mL) of TMB. The off-chip UV-vis spectra and
on-chip temperature measurement were applied to characterize the optimization process, with the
absorbances at 650 nm and 810 nm representing the typical peaks of the colorimetric and the
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NIR photothermal absorption. As results shown in Figure 4.6, the absorbances at 650 nm
increase from 0.075 to 0.6 nM, and no obvious change occurs when the concentration is higher
than 0.6 nM. This result can be explained that the maximum or saturated amount of ox-TMB was
produced at 0.6 nM of AuNPs. In addition, the absorbances at 810 nm increase in the range of
0.075-0.6 nM and reach a plateau afterward, indicating the maximum NIR absorption at the
AuNPs concentration of 0.6 nM. Under the NIR laser irradiation, rapid temperature increases
were observed when increasing AuNPs concentrations from 0.075 to 0.6 nM. The highest
temperature increase (ΔT higher than 12 °C) was achieved at the AuNPs concentration of 0.6
nM, while no significant temperature changes were observed in the AuNPs concentration range
of 0.6-1.2 nM. Therefore, 0.6 nM was selected as the optimal concentration of AuNPs and used
in the following experiments.
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Figure 4.6: AuNPs concentration optimization in the AuNP-catalyzed TMB oxidization reaction
system. (A) UV-vis spectra, (B) absorbances at 650 nm and 810 nm, and (C) onchip temperature measurement of reaction solutions with different AuNPs
concentrations. The laser power density was 0.16 W/mm2, and the irradiation time
was 5 min. Error bars indicate standard deviations (n = 3).
4.3.3 Characterization of DNA-AuNPs conjugates
In the following AuNP-mediated photothermal biosensing of the target DNA, the DNA
probe-AuNP conjugates instead of bare AuNPs were used as the catalyst for the photothermal
biosensing probe (ox-TMB). A constant concentration ratio between the DNA probes and bare
AuNPs was used in the synthesis of the DNA probe-AuNP conjugates. The obtained conjugates
74

were characterized via UV-vis spectroscopy. The results are shown in Figure 4.7. A peak shift
from 520 nm to 530 nm was observed for the conjugates when comparing with bare AuNPs. This
result was attributed to the bioconjugation between AuNPs and oligonucleotides, leading to the
change of surface charges on AuNPs.187 The concentration of AuNPs in the obtained conjugates
was calculated based on the extinction coefficient of 8.78 x 108 M-1·cm-1,188,189 and the
concentration of conjugated DNA probes was confirmed using the NanoDrop spectrophotometer.
The final molar concentration ratio of the DNA probe-AuNP conjugates was obtained as 220:1
between DNA probes and AuNPs in the subsequent photothermal biosensing.

Figure 4.7: UV-vis characterization of the bare AuNPs and the DNA probe-AuNP conjugates.
4.3.4 Kinetic studies of the photothermal biosensing process
The irradiation time is another important factor to affect the biosensing signals and
detection performance, and therefore the effect of the irradiation time was characterized by
investigating the kinetic studies in photothermal biosensing of the target DNA. The continuous
laser irradiation was used to irradiate different samples, containing both the control (in the
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absence of the target DNA) and a sample (in the presence of 10 µM target DNA), and the
dynamic temperature changes of both samples were monitored up to 6 min. As results shown in
Figure 4.8A, no obvious temperature increase occurs in the control in comparison with room
temperature (~ 23 °C). In the presence of 10 µM target DNA, the temperature increased rapidly
from 23 to 33 °C in the first 120 s, which was mainly due to the strong photothermal conversion
under laser irradiation (Figure 4.8B). The temperature of the sample increased slowly from 120 s
to 180 s, which might be affected by the competitive heat loss to the surroundings against
photothermal heat generation. At around 3 min, the highest temperature value of ~ 35 °C was
observed, suggesting the temperature measurement reached a balance point between heat
generation and heat loss. When irradiation time was longer than 3 min, the temperature
decreased gradually owing to heat loss as the predominant factor in dynamic measurements.
Therefore, 3 min of laser irradiation time was selected in the following experiments to get the
sensitive photothermal biosensing of target DNA.
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Figure 4.8: Kinetic studies of the photothermal biosensing process. (A) Dynamic temperature
measurement of the control (containing 0 µM of the target DNA) and the sample
(containing 10 µM of the target DNA) under continuous laser irradiation. The laser
power density was 0.16 W/mm2. (B) Schematic illustration of
competitive effects between heat generation and heat
loss during the photothermal biosensing process.
4.3.5 Calibration curve and limit of detection
The photothermal detection of MTB DNA on the paper hybrid device was performed by
recording temperature increases of samples using a thermometer under optimal conditions.
Different concentrations of MTB DNA samples in the range of 0-50 µM were tested. The results
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are shown in Figure 4.9. In the presence of target DNA (50 µM), a clear blue color was
observed, while there was no color change observed in the absence of target DNA (0 µM) as
seen in insets (a-b). In the temperature-based photothermal detection, the temperature of samples
increased when increasing the concentration of target DNA and reached a ΔT value of nearly 17
°C at 50 µM of target DNA. A linear relationship was obtained between temperature increases
and the logarithmic concentrations of synthetic target DNA in the range of 100 nM to 50 µM.
The square of the correlation coefficient was 0.987, with a slope of 5.099 °C·µMˉ1. The limit of
detection (LOD) was calculated as 39 nM (or 0.58 µg/mL) based on the 3-fold standard
deviation over the blank.

78

Figure 4.9: Quantitative photothermal biosensing of MTB DNA on the paper hybrid microfluidic
device using a thermometer. The calibration curve of temperature increase was
plotted versus the logarithmic concentration of target MTB DNA in the range of 0.1
to 50 µM. Insets are photographs of biosensing samples at the target concentrations
of (a) 0 µM, (b) 50 µM, and (c) 50 µM using blood-mimicking dye solutions (scale
bar: 5 mm). The laser power density was 0.16 W/mm2, and the irradiation time was
3 min. Error bars indicate standard deviations (n = 6).
Compared with conventional colorimetric detection methods,149,190,191 this proposed
photothermal detection method has several significant benefits. First, higher sensitivity has been
achieved for the photothermal detection of target DNA, with a lower LOD value (0.58 µg/mL)
than those reported ones based on colorimetric signals (LODs: 10 µg/mL,149 1.88 µg/mL,190 or
1.14 µg/mL,191). Besides, only a simple and inexpensive thermometer is needed as the signal
reader for quantitative detection of DNA, avoiding the need for bulky and costly instruments
(such as spectrophotometers), which significantly reduces the bioassay cost. Furthermore, by
using temperature readouts, quantitative detection of the target DNA can eliminate color
interference from the sample matrix, which is usually a common problem in the colorimetric
biosensing methods when testing colored real samples, such as blood matrices. Herein, we used a
food dye (red color) to mimic a real matrix (blood samples) in the biosensing of the target DNA,
and a pink color was observed in inset (c) instead of a blue color (inset (b)). It was suggested that
the observation of blue colored ox-TMB products was interfered remarkably due to the red color
background. However, there was such an interference issue in the thermometer-based method,
therefore demonstrating another advantage of this photothermal biosensing method over the
colorimetric method.
4.3.6 Specificity tests
To validate the photothermal biosensing method, genomic DNA samples instead of
synthetic sequences were used in the specificity tests. In addition to MTB genomic DNA, other
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interfering species were used including water as blank, PBS buffer, TB knockout DNA, M.
Smegmatis, and M. Marinum. It was noted that M. Smegmatis was selected as a non-pathogenic
bacterium, which has been widely used as an alternative for MTB due to the fast growth and the
requirement of low biosafety level facility.192 ), A non-pathogenic DNA mixture from the above
species were also used containing M. Smegmatis and TB knockout. M. Marinum was used a
pathogenic non-tuberculous mycobacterium compared to MTB.193 The results are shown in
Figure 4.10. There was a significant temperature increase (ΔT of 8 °C) observed in the detection
of MTB genomic DNA at a 2-fold lower concentration than others. The analytical recovery was
calculated to be 113 ± 1%. When testing blank, PBS buffer, TB knockout DNA, and M.
Smegmatis DNA, neglectable temperature increases were obtained with ΔTs smaller than 3 °C.
A mild temperature increase of 5 °C was obtained when testing M. Marinum genomic DNA at 2fold higher concentrations than the target MTB genomic DNA. The result can be explained by
the fact that a high percent identity (over 80%) exists in genomes between MTB and M.
Marinum.194,195 Even when testing a mixture of DNA interference samples containing M.
Smegmatis and TB knockout, the photothermal biosensing signals remained insignificant
according to statistical analysis, resulting in a temperature increase of only 1.3 °C. Therefore, a
conclusion can be carefully drawn that the proposed photothermal biosensing method has high
specificity even when distinguishing between species with high similarity.
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Figure 4.10: Specificity tests of the photothermal biosensing of genomic MTB DNA on the paper
hybrid microfluidic device using a thermometer. Temperature increases of samples
containing water as blank, PBS buffer, TB knockout DNA (50 µg/mL), M.
Smegmatis DNA (50 µg/mL), mixture species (M. Smegmatis and TB knockout, at
a final DNA concentration of 50 µg/mL), M. Marinum DNA (50 µg/mL), and
genomic MTB DNA (25 µg/mL). The laser power density was 0.16 W/mm2, and the
irradiation time was 3 min. Error bars indicate standard deviations (n = 6).
(Statistical significance was calculated using Student’s t-test; ns indicates not
significant between the two groups, p > 0.05.)
4.4

Summary
In conclusion, we have developed a low-cost photothermal biosensing method for

quantitative MTB DNA detection on a paper hybrid device using a thermometer. By integrating
the AuNP-mediated photothermal effect to bioassays, the target DNA was quantitatively detected
using temperature as analytical readouts. Higher sensitivity with no color interference was
achieved using this method in comparison with conventional colorimetric methods. The whole
assay can be completed within 2 h on a low-cost paper/polymer hybrid device, with the material
cost of $0.08 for each device. There is no need for any expensive instrumentation and
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complicated nucleic acid amplification in this method. High specificity was obtained by
detecting genomic DNA samples even with high similarity. To the best of our knowledge, this is
the first attempt to perform photothermal genetic analysis on paper hybrid microfluidic devices,
providing a simple, low-cost, rapid, and quantitative photothermal microfluidic biosensing
platform. It is also anticipated that with the development of commercially available portable
lasers, this platform can be further adapted for POC diagnostics of various diseases by enhancing
its portability. Moreover, this nucleic acid hybridization-based genetic analysis method also
provides merits over conventional detection methods, such as DNA microarray, including
simplicity, ease of operation, low cost, which is due to the use of paper substrates instead of glass
slides. Given the enormous genetic analysis-based biological applications including infectious
disease diagnosis, this photothermal biosensing platform has great potential in the field of POC
disease diagnosis, especially in resource-poor settings.
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Chapter 5: Fe3O4 NP-Mediated Portable Photothermal Immunosensing of Hepatitis C
Using a Thermometer

•

This

chapter develops

a simple, portable, low-cost,

and

quantitative

immunosensing method based on Fe3O4 NPs-mediated photothermal effects for
protein-based diagnostics of infectious diseases (hepatitis C) using a thermometer.
•

By using the hepatitis C virus core antigen (HCVcAg) as a model target protein,
the photothermal immunosensing method is achieved only using a common
thermometer

as

the

signal

reader,

while

no

sophisticated

analytical

instrumentation is needed.
•

An inexpensive and portable NIR laser pointer is applied as the light irradiation
source, which further reduces the detection cost and enhances the portability of
the photothermal immunosensing platform.

•

This proposed method provides comparable sensitivity with that from commercial
ELISA kits using spectrophotometers, and high specificity as well as good
analytical recoveries when detection HCVcAg in serum samples.
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5.1

Introduction
Hepatitis C as a global health problem is caused by the hepatitis C virus (HCV) infection,

and mainly transmitted through contact with blood from infected persons.196 According to the
World health organization, there are 3-4 million infected cases reported each year in the
worldwide.196,197 Although over 50% of HCV cases become the long-term chronic infection,
hepatitis C can also result in severe complications and life-threatening health issues, such as
cirrhosis, liver failure, and liver cancer.198,199 Getting tested for hepatitis C plays a vital role in
the early diagnosis, efficient management, and timely treatment of both active and chronic HCV
infection, particularly when there is no vaccine currently available for hepatitis C.
Currently, several laboratory diagnostic tests have been used to detect HCV infection,
which mainly rely on serological immunoassays and nucleic acid techniques (NAT).200,201 The
detection of hepatitis C virus core antigen (HCVcAg) have attracted more attention in recent
years, because these assays are relatively simpler and less expensive, and require less operation
time than NAT testing.200,202,203 Several HCVcAg detection kits have been developed and
commercially available, which are based on the chemiluminescent enzyme immunoassays
(CLEIA) or ELISAs. However, bulky and advanced analytical instruments (such as microplate
readers) are still needed for the sensitive and quantitative detection of HCVcAg, which limits the
wide accessibility in the resource-constrained areas.
Recently, the quantitative detection of biomolecules based on the nanomaterial-mediated
photothermal effects has become popular and been applied in different research fields, including
disease diagnostics.36,42,81-83,180,181 (The principle of nanomaterial-mediated photothermal effects
can be referred to Section 1.2, Chapter 1.) Since the first photothermal immunoassay developed
by our group,81 there have been several works reported for the detection of biomarkers for
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various cancer diseases, such as prostate cancer and pancreatic cancer.36,42,83,180,181 Basically,
different nanomaterials were introduced to conventional immunoassays, which were directly
used as the photothermal biosensing probes (such as PB NPs),81 or used to produce the
photothermal biosensing probes (such as the oxidized TMB).42 Under the irradiation of lasers at
a specific wavelength (e.g. 808 nm), the photon energy can be converted to thermal energy by
these photothermal probes, leading to significant temperature increases. Therefore, the
quantification of biomolecules was achieved by only using a thermometer as a signal recorder.
Despite the simplicity and convenience, there are still improvements needed in current
photothermal immunosensing platforms. For instance, most of the current methods require
multifaceted laser diodes as light sources, which can be expensive, need dedicated electrical
connections, and occupy large space. The photothermal immunoassays are herein strictly limited
in regard to affordability, portability, and flexibility, thus limiting the wide POC applications.
To address these issues, we, for the first, integrated a handheld portable laser pointer in
the photothermal immunosensing platform, and developed a quantitative detection method for
biomolecules using a common thermometer. As proof of concept, this platform was used to
detect HCVcAg (as a model target). In a typical immunoassay, the HCVcAg was recognized by
the primary antibody and the iron oxide nanoparticles (Fe3O4 NPs)-labeled secondary antibody.
The Fe3O4 NPs were then served as a nanoenzyme owing to the intrinsic peroxidase-like activity
and catalyzed the oxidization of TMB in the presence of hydrogen peroxide (H2O2).42,204,205 The
as-produced oxidized TMB (ox-TMB) with a blue color was applied as a strong photothermal
probe,42 and caused temperature increase under the irradiation of a portable laser pointer.
Therefore, the quantitative detection of HCVcAg was obtained by measuring temperature
changes using a thermometer. The presented method achieved comparable sensitivity in
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comparison with the commercial ELISA kit with no assist of any advanced analytical
instruments and bulky laser diodes. Validation of this method was confirmed in the testing of
various interference substances and spiked serum samples, offering a promising platform for
simple, low-cost, and portable quantitative biomolecular detection at the point of care.
5.2

Experimental section

5.2.1 Materials and reagents
All chemicals and reagents used in this work were listed in Section 2.1 (Chapter 2). The
concentrations of antibodies and antigens were determined via a NanoDrop spectrophotometer
(Sigma-Aldrich, St. Louis, MO, USA). All reagents were used as received without further
purification.
In the characterization, a microplate reader (Molecular Devices, LLC, Sunnyvale, CA,
US) was used to obtain the UV-vis spectra. A portable NIR laser pointer (Model PL-E Pro, 808
nm, 2.5 W) was purchased from Jet Lasers Photonics Devices Co., Ltd (Xi’an, China) and used
as the light source. A digital thermometer (Model 421502, Extech Instruments Corporation, US)
was used to monitor temperature changes in the photothermal immunosensing.
5.2.2 Procedures of photothermal immunosensing of HCVcAg using a thermometer
The synthetic procedures of the Fe3O4 NP-labeled secondary antibody conjugates were
described in detail in Chapter 2. The conjugates were freshly prepared and kept at 4 °C before
using.
The target biomolecules (HCVcAg, 120 µL per tube) at varying concentrations were first
incubated overnight in PCR tubes at 4 °C. A 5% BSA solution (180 µL) was then used to block
any remaining active sites, followed by incubation at 37 °C for 30 min. The primary antibody
(120 µL per tube) was added after the blocking steps and incubated for 1 h, followed by the
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addition of the synthesized Fe3O4 NPs-labeled secondary antibody (120 µL per tube). After
further incubation for 1 h, the tubes were washed thoroughly to remove the nonspecific binding.
A 180 µL of chromogenic substrate mixture containing TMB (0.4 mM), H2O2 (5%), and citrate
buffer (pH 4.5) was added to each tube for 20 min further reaction. Finally, the obtained samples
were irradiated by using a NIR portable laser. The temperature increase was recorded using a
thermometer immediately after the laser irradiation. Detailed information about photothermal
detection using the thermometer can be referred to Section 2.3 (Chapter 2).
In the condition optimization, similar procedures were conducted except adding different
concentrations of the primary antibody or the Fe3O4 NP-labeled secondary antibody conjugates,
applying different reaction time for Fe3O4 NP-mediated TMB oxidization, or the laser irradiation
time, respectively.
5.3

Results and discussion

5.3.1 Working principle and feasibility tests
The portable photothermal detection of HCVcAg using a thermometer is achieved based
on the nanomaterial-mediated photothermal immunosensing principle. As illustrated in Figure
5.1, in a conventional ELISA, HCVcAg is first immobilized and recognized by primary
antibodies, followed by binding with the Fe3O4 NPs-labeled secondary antibody, in which Fe3O4
NPs are introduced into immunoassays. The Fe3O4 NPs as nanoenzymes are applied to catalyze
the oxidization of a chromogenic substrate TMB, forming its oxidized form (ox-TMB) due to the
peroxidase mimicking property of Fe3O4 NPs. The product ox-TMB shows an obvious blue color
compared to the colorless substrate TMB, and can be used as a strong photothermal probe due to
its efficient light-to-heat conversion in the NIR range, which has been confirmed by our previous
studies.42 Under the irradiation of a portable NIR laser, temperature increases and is recorded
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using a common thermometer. With the increasing concentration of HCVcAg, more ox-TMB is
produced with a darker color, and more thermal energy can be accumulated, resulting in higher
temperature increases. Therefore, the target HCVcAg can be not only qualitatively detected by
visualizing the color change, but also quantitatively detected through this portable photothermal
detection method using a thermometer. Importantly, this method negates the need for costly and
bulky advanced analytical instruments, which significantly decreases the complexity and the
detection cost of quantitative bioassays. Moreover, by applying a portable laser pointer as the
light source, there is no need for conventional sizable laser systems, which further decreases the
assay cost and remarkably improves the portability of the photothermal immunoassays.

Figure 5.1: Schematic illustration of the quantitative photothermal detection of HCVcAg using a
portable laser and a thermometer based on the Fe3O4 NPs-mediated photothermal
effects.
The feasibility of the Fe3O4 NPs-mediated photothermal effect was first investigated by
testing different components in the Fe3O4 NPs-catalyzed TMB-H2O2 system. UV-vis spectra and
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temperature measurements were conducted to characterize the system. As shown in Figure 5.2A,
different components were tested in samples (1-7), referring different combinations of the
substrate (TMB), the oxidizing reagent (H2O2), and Fe3O4 NPs. Compared with samples (1-6),
only sample (7) exhibited obvious color change from colorless to blue with a typical absorbance
peak at around 650 nm (Figure 5.2B). The results indicated that the ox-TMB was produced in the
presence of Fe3O4 NPs, confirming the excellent peroxidase mimicking the property of Fe3O4
NPs.42 No such color change and absorbance peaks were observed in the sample (1-6), implying
no occurrence of the TMB oxidization reaction. Furthermore, strong absorption in the sample (7)
appeared in the NIR range, suggesting the great potential of applying ox-TMB as a photothermal
probe. In the photothermal measurement, a temperature increase over 10 °C was obtained in the
sample (7) under the irradiation of a portable NIR laser pointer, which was distinct from other
samples with negligible temperature increases (Figure 5.2C). These results further confirmed that
Fe3O4 NPs can be used as nanoenzymes to catalyze the oxidization of TMB, producing a strong
photothermal probe. Additionally, the feasibility was proved when applying Fe3O4 NPs-mediated
photothermal effects in the following detection method.
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Figure 5.2: Feasibility tests of the Fe3O4 NPs-mediated photothermal detection method. (A)
Different component compositions, (B) UV-vis spectra, and (C) temperature
changes of samples (1-7) in the Fe3O4 NPs-catalyzed TMB-H2O2 reaction system.
Insets are photographs of the corresponding samples. The laser power density was
0.2 W/mm2, and the irradiation time was 2 min. Error bars indicate standard
deviations (n = 3).
5.3.2 Characterization of the Fe3O4 NPs-catalyzed TMB-H2O2 reaction system
To achieve the quantitative photothermal detection strategy, it is important to investigate
the relationship between the readouts and the concentrations of Fe3O4 NPs (nanoenzymes) in the
Fe3O4 NPs-catalyzed TMB-H2O2 system. Both UV-vis spectroscopy and photothermal
measurement were conducted to characterize this system. As results shown in Figure 5.3A-B,
with the addition of Fe3O4 NPs at different concentrations from 0 to 0.5 mg/mL, color changes
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from colorless to blue were observed with the increasing absorbance at 650 nm (a characteristic
absorption peak of ox-TMB).42 The results indicated the production of ox-TMB was dependent
on the Fe3O4 NPs concentration, which was consistent with our previous studies applying oxTMB as a colorimetric probe.42 Furthermore, as seen in Figure 5.3C, the absorbance at 810 nm
increased and was positively proportional to the concentration of Fe3O4 NPs in the range of 0-0.5
mg/mL, implying that the NIR light absorption of the photothermal probe (ox-TMB) was
quantitatively reliant on the Fe3O4 NPs concentration. Moreover, in the photothermal
measurement, the temperature increase was linearly correlated with the logarithmic
concentration of Fe3O4 NPs in the range of 0.025-0.5 mg/mL, with the coefficient of
determination of 0.992 (Figure 5.3D). The results revealed the quantitative relationship between
the concentration of Fe3O4 NPs and the photothermal readout (i.e. temperature increase) in the
Fe3O4 NPs-catalyzed TMB-H2O2 reaction system. The characterization results also affirmed that
it is feasible to apply the Fe3O4 NPs-mediated photothermal effect in the quantitative
photothermal immunoassay.
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Figure 5.3: Colorimetric and photothermal characterization of the Fe3O4 NPs-catalyzed TMBH2O2 reaction system. (A) Color changes of sample solutions upon the addition of
Fe3O4 NPs in the concentration range of 0-0.5 mg/mL. (B) UV-vis spectra of the
above solutions. (C) Plot of the absorbance at 810 nm versus the Fe3O4 NPs
concentration. (D) Plot of the temperature increase versus the logarithmic
concentration of Fe3O4 NPs. The laser power density was 0.2 W/mm2, and the
irradiation time was 2 min. Error bars indicate standard deviations (n = 3).
5.3.3 Optimization of antibody concentrations
The concentrations of immunecomponents affect the immunorecognition performance
and the subsequent detection process. Therefore, in order to get the best immunosensing results,
the concentrations of both primary antibodies and Fe3O4 NPs-labeled secondary antibodies were
optimized in the photothermal detection of HCVcAg. Specifically, different antibody
concentrations were applied accordingly in a conventional immunorecognition procedure, with
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the concentration ranges of 0-20 µg/mL for primary antibodies and 0-40 µg/mL for Fe3O4 NPslabeled secondary antibodies, respectively. The substrate solution containing TMB and H2O2 was
added for the Fe3O4 NPs-catalyzed oxidation reaction. The obtained solution was then irradiated
by the NIR portable laser, and the temperature changes were recorded after 5 min. As results
shown in Figure 5.4, the temperature increased gradually in the ranges of 0-10 µg/mL for
primary antibodies and 0-20 µg/mL for secondary antibodies. This phenomenon can be
explained by the substantial heat generation due to the photothermal effect of the as-produced
ox-TMB with increasing amounts. The temperature elevations reached the maximum values
around 8 °C at the primary antibody concentration of 10 µg/mL and the secondary antibody
concentration of 20 µg/mL, achieving the highest photothermal readouts. Lower temperature
elevations were observed even when adding higher concentrations of antibodies, which might be
attributed to complex effects from heat loss to surroundings and the intrinsic kinetics of
immunochemical reactions.206 Hence, to get the maximum sensing signal and high sensitivity, 10
µg/mL and 20 µg/mL were selected as the optimal concentrations for primary antibodies and
secondary antibodies, respectively.
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Figure 5.4: Concentration optimization of (A) the anti-HCVcAg antibody and (B) the Fe3O4
NPs-labeled anti-IgG antibody. Plots of temperature increases versus different
antibody concentrations. The laser power density was 0.2 W/mm2, and the
irradiation time was 5 min. Error bars indicate standard deviations (n = 3).
5.3.4 Optimization of the Fe3O4 NPs-catalyzed TMB oxidization reaction time
In the Fe3O4 NPs-mediated photothermal immunoassay, the TMB oxidization reaction
time plays a pivotal role in the production of ox-TMB (serving as a photothermal probe), which
was optimized herein. The absorbance at 650 nm was used as a characteristic absorption of oxTMB,42 while the absorbance at 810 nm represented the NIR absorption of ox-TMB as well as its
photothermal sensing ability. From Figure 5.5, a steep increase of the absorbance at 650 nm was
observed in the first 20 min, indicating a rapid production of ox-TMB from the catalytic
oxidization reaction. The absorbance then increased slowly from 20 min up to 1 h, representing
the sluggish accumulation of ox-TMB products. Moreover, with the prolonged reaction time, the
absorbance at 810 nm increased first and reached a plateau at 20 min. The results suggested that
increasing reaction time over 20 min has little effect on the NIR-induced photothermal sensing
ability, despite the slow oxidization of TMB. Therefore, to obtain the optimal temperature
readout while shortening the reaction time, 20 min of reaction time was used in the following
experiments.
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Figure 5.5: Optimization of the Fe3O4 NPs-catalyzed TMB oxidization reaction time. Plot of
absorbances at 650 nm and 810 nm versus different reaction time from 0-60 min.
5.3.5 Optimization of the laser irradiation time
The irradiation time has a significant influence on the temperature readouts and was also
optimized in the photothermal detection method. Basically, by using the portable laser as the
NIR light source, a continuous laser irradiation process was performed. The temperatures of both
an immunosensing sample (containing 5 ng/mL of HCVcAg) and a control (containing 0 ng/mL
of HCVcAg) were monitored from 0-390 s and recorded every 30 s. As seen in Figure 5.6, the
temperature of the immunosensing sample increased quickly from room temperature (~ 22 °C) to
nearly 32 °C within 2 min and reached a plateau thereafter. However, only a slight temperature
increase (around 3 °C) was recorded in the control. As such, 2 min was chosen to be the optimal
irradiation time for the subsequent photothermal tests.
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Figure 5.6: Optimization the laser irradiation time in the photothermal immunoassay. Plot of
temperature increase versus continuous laser irradiation time from 0-390 s. The
control and immunosensing samples contained 0 and 5 ng/mL of HCVcAg,
respectively. The laser power density was 0.2 W/mm2.
5.3.6 Calibration curve and the detection limit
Under all optimal conditions, the Fe3O4 NPs-mediated photothermal immunoassay was
conducted for the quantitative detection of HCVcAg. Samples containing HCVcAg with
different concentrations from 0-120 nM were irradiated by a portable NIR laser, and the
temperature readouts were acquired by using a common thermometer. As seen from Figure 5.7A,
when HCVcAg with the increasing concentration was spiked in the PBS buffer, the temperature
of samples increased accordingly up to a ΔT value of nearly 20 °C. There was a linear
relationship obtained between the temperature increase and the logarithmic concentration in the
range of 5-120 nM, with the coefficient of determination as 0.972. The limit of detection (LOD)
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was calculated to be 2.2 nM based on 3-fold of the standard deviation above the blank, which is
comparable to the sensitivity from the commercial ELISA kit using spectrophotometers (e.g.
LOD: 1.0 ng/mL, from Cell Biolabs, Inc).
This photothermal immunoassay was also validated in practical applications using human
serum samples. As seen in Figure 5.7B, when the target HCVcAg was spiked in 3-fold diluted
normal human serum samples, the temperature increased at higher concentrations. A maximum
ΔT value over 18 °C was observed when the HCVcAg concentration was 120 ng/mL. The
temperature increase was linearly correlated with the logarithmic concentration of HCVcAg. The
detection range was 10-120 nM, and the LOD was obtained as 4.3 nM. The results confirmed
this photothermal immunoassay was also suitable for the detection of HCVcAg in the
complicated matrix (i.e. human serum).
This proposed method is advantageous over current immunoassays in several aspects.
First, only a thermometer is needed as a signal recorder in this photothermal immunosensing
method, which has achieved the quantitative detection of biomolecules. However, most reported
methods have relied on bulky and expensive analytical instruments, such as microplate
readers,207 fluorescence spectrometer,208 electronic workstations,209 etc. Moreover, Fe3O4 NPs
are applied as nanoenzymes to mimic peroxidase and catalyze the oxidization of TMB substrates,
which are much more robust and stable, less expensive, and less prone to environmental
conditions (e.g. temperature) in comparison with natural enzymes (like horseradish peroxidase or
HRP).27,28 In addition, compared to current photothermal immunosensing platforms,42,81,83,180,181
an inexpensive and small-sized portable laser was used as the NIR light source, which has
significantly improved the portability of photothermal bioassays with a cost-effective and spacesaving experimental setup.
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Figure 5.7: Quantitative photothermal detection of HCVcAg using a portable laser and a
thermometer. Calibration curves of temperature increase versus the logarithmic
concentration of HCVcAg spiked in (A) the PBS buffer and (B) the 3-fold diluted
human serum samples. The laser power density was 0.2 W/mm2, and the irradiation
time was 2 min. Error bars indicate standard deviations (n = 3).
5.3.7 Specificity tests
The specificity of the photothermal immunosensing of HCVcAg was evaluated by testing
different types of common interfering substances, including human serum as the control,
hepatitis B virus core antigen (HBVcAg), carcinoembryonic antigen (CEA), prostate-specific
antigen (PSA), and bovine serum albumin (BSA). All these interfering substances and the target
HCVcAg were spiked in 3-fold diluted normal human serum samples at the concentrations of 30
ng/mL and 10 ng/mL, respectively. The photothermal measurement was conducted under
optimal conditions, and the results are in Figure 5.8. There was an obvious temperature increase
over 10 °C obtained in the detection of the target HCVcAg. Nonetheless, the tests for all
interfering substances had negligent temperature increases, although the interfering substances
were at 3-fold higher concentrations than the target HCVcAg. Therefore, the results disclosed the
high specificity of this portable photothermal immunosensing platform for the detection of
HCVcAg.
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Figure 5.8: Specificity tests using different interference substances at 3-fold higher
concentrations than the target HCVcAg, including human serum as a control,
HBVcAg, CEA, PSA, and BSA. The laser power density was 0.2 W/mm2, and the
irradiation time was 2 min. Error bars indicate standard deviations (n = 3).
5.3.8 Analytical recovery
The analytical recoveries were tested to further validate this photothermal
immunosensing method. The target HCVcAg at different concentrations (i.e. 10 ng/mL for
Sample 1 and 40 ng/mL for Sample 2) was detected in the photothermal immunosensing
platform. Different spiking media were used including the PBS buffer and the 3-fold diluted
serum samples. As shown in Figure 5.9A, with increasing amounts of target biomolecules, the
temperature of spiked samples increased accordingly with the maximum values around 16 °C,
while the temperature increases of control samples using the PBS and the serum matrix were
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obtained as 5.3 and 5.2 °C, respectively. Besides, at the same HCVcAg concentration of 10
ng/mL, led to 11.2 and 9.8 °C of temperature increases in the PBS buffer and the human serum
media, respectively. Similarly, at 40 ng/mL of HCVcAg, temperature increases of the spiked
samples (Sample 2) reached 15.5 and 15.8 °C using the PBS buffer and the human serum as the
matrix, respectively. Consequently, the analytical recoveries of serum-spiked samples (Sample 1
and 2) were calculated in the range of 98.3-108.9% with the relative standard deviations (RSDs)
within 3.1-6.2% (Figure 5.9B). The results confirmed that there was little effect from serum
samples on the photothermal immunosensing results, and further validated the good analytical
performance for HCVcAg detection even in the complex medium (i.e. human serum).
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Figure 5.9: Analytical recovery of the portable photothermal detection of HCVcAg using a
thermometer. (A) Temperature increases of different samples spiked in the PBS
buffer and the 3-fold diluted human serum, respectively. The control, sample 1, and
sample 2 contained 0, 10, and 40 ng/mL of HCVcAg, respectively. (B) The
analytical recoveries obtained from the spiked samples in 3-fold diluted human
serum. Results were obtained from three replicas. The laser power density was 0.2
W/mm2, and the irradiation time was 2 min.
5.4

Summary
In summary, a portable biomolecular detection method was developed based on the

Fe3O4 NPs-mediated photothermal immunoassay for infectious disease diagnosis. In this method,
a portable laser pointer was used as the light source to trigger the photothermal detection, and the
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target HCVcAg can be detected with only a thermometer as a signal recorder. High sensitivity
was achieved in this photothermal immunosensing method, which was comparable with that of
the commercial ELISA kit using bulky and expensive analytical instruments. The detection
method was also validated by testing HCVcAg in human serum samples, attaining high
specificity and good performance for photothermal bioanalysis. In addition, compared to most of
the current photothermal biosensing platforms, this method has provided outstanding benefits by
applying the laser pointer, such as the remarkably reduced cost of lasers (nearly 10-fold cheaper
than using a laser diode), the space-saving experimental setup (with the total laser size of 28 ×
3.5 cm), and improved portability (using built-in-rechargeable batteries). Hence, the proposed
strategy provides a simple, low-cost, portable, and reliable photothermal biosensing platform for
quantitative detection of biomolecules, which has opened great possibilities for a broad scope of
POC diagnostics for various diseases, such as infectious diseases and cancers.
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Chapter 6: Photothermal Immunosensing of PSA Using an immuno-PT-Chip

Reproduced in part with permission from the Royal Society of Chemistry.
•

Parts of this chapter were published in Lab on a Chip as a research article in 2020.
(Lab Chip, 2020, 20, 2218-2227.)

•

This chapter presents a simple, low-cost, and visual quantitative POC diagnostic
device, immuno-PT-Chip (i.e. the photothermal effects-driven volumetric barchart immunosensing microchip), for cancer biomarker detection, which for the
first time integrates photothermal immunosensing and bar-chart microfluidic
platforms.

•

By using this immuno-PT-Chip, conventional immunosensing signals can be
converted to readable signals, the on-chip bar-chart movements, and the
quantification of biomolecules can be readily achieved without the aid of any
complex analytical instruments or even thermometers.

•

As a proof of concept, the prostate-specific antigen (PSA) was used as a model
analyte and detected on the immuno-PT-Chip without using any instruments,
achieving high sensitivity and specificity, which meets the cut-off requirement for
clinical diagnosis of prostate cancer.

•

The immuno-PT-Chip is further validated by testing PSA in human serum and
whole blood samples, demonstrating good analytical performance even in the
complex matrix.
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6.1

Introduction
Biomarkers play an important role in the diagnosis, prognosis, and treatment of a broad

range of diseases including cancers.37-39 The detection of cancer biomarkers provides crucial
information to guide prognostic and therapeutic decisions.38 Currently, there are various methods
developed for the detection of protein-based cancer biomarkers, such as surface plasmon
resonance

(SPR),40

colorimetry,41

fluorescence,43

electrochemistry,44,210

and

chemiluminescence.45 However, the conventional methods have posed several limitations in the
POC detection of biomarkers. For instance, the colorimetric detection technique widely used in
ELISAs provides quantitative measurements of target proteins, leveraging its simple and
visualized color changes. Nonetheless, high sensitivity and specificity of these methods are often
compromised,211 and rely on expensive biochemicals (e.g. enzymes), costly and bulky analytical
instruments (e.g. spectrophotometers), and specialized professionals. Therefore, there has been a
sustained interest to develop new immunoassay strategies for simple, low-cost, and sensitive
POC detection of protein biomarkers.
Microfluidic lab-on-a-chip (LOC) technology provides a promising POC diagnostic tool,
with outstanding benefits such as low reagent consumption, miniaturization, high degrees of
integration, and portability.13,85-87,111,210,212 (The evolution of microfluidic devices has been
discussed in Section 1.3, Chapter 1.) For example, a new POC microfluidic platform has been
developed by Qin and co-workers, namely the volumetric bar-chart microfluidic chip (V-Chip),
which shows great potential for visual biochemical quantitation.118 By applying catalase as the
ELISA probe, oxygen was generated and accumulated within V-Chips, leading to a sustained
increase of pressure. The preloaded inks were then pushed to move through microfluidic
channels on the V-Chip. The as-produced moving distances were thus correlated with the
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concentration of target molecules, therefore, leading to the quantitative detection of analytes. By
combining different immunoassays with V-Chips, several POC detection platforms have been
developed thereafter based on the instrument-free biosensing readouts.119,122,123 Despite the
promising potential in POC testing, there are several technical hurdles to overcome in order to
explore more applications. For instance, glass slides as relatively expensive materials (e.g.
compared with polymers) were used to fabricate V-Chips, causing the increasing cost and
complicated preparation procedures (e.g. cleaning and etching of glass slides). Besides, good
sealing performance of V-Chips was crucial, which required specific configurations in microchip
assembly and alignment, resulting in the increasing complexity of chip designs. Moreover, the
biosensing signals on V-Chips were based on gas generation via chemical reactions, lacking
remote and accurate controllability. All these limitations have motivated the improvement of VChips, especially in two aspects, selecting alternative materials (e.g. thermoplastics) and
introducing new robust microfluidic driving forces.
Nanomaterial-mediated photothermal effects have recently attracted intensive interest
because of the unique light-to-heat conversion property and the excellent compatibility in many
bioanalysis platforms.36,42,81-83,180,181 (The principle of nanomaterial-mediated photothermal
effects can be referred to Section 1.2, Chapter 1.) For example, our lab has introduced the
nanomaterial-mediated photothermal effect to ELISA and developed the first photothermal
immunoassay for the quantitative detection of cancer biomarkers using a thermometer, avoiding
the need for expensive analytical instruments.81 Several photothermal biosensing platforms have
been developed afterward to detect a broad range of targets, ranging from proteins, nucleic acids,
and environmental pollutants.36,42,81-83,180,181 Despite the promising bioanalysis applications of
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nanomaterial-mediated photothermal effects, there are very few reports integrating photothermal
immunoassays with microfluidic LOC platforms.
Herein, we first designed a hybrid microfluidic chip for photothermal immunosensing of
cancer biomarkers using two inexpensive materials, poly (methyl methacrylate) (PMMA) and
polydimethylsiloxane (PDMS). By introducing the iron oxide nanoparticles (Fe3O4 NPs)mediated photothermal effect into the volumetric bar-chart hybrid microchip, the obtained
immuno-PT-Chip was used for visual quantitative immunosensing of protein-based biomarkers.
In this strategy, Fe3O4 NPs involved in a typical sandwich immunoassay were converted to
Prussian blue nanoparticles (PB NPs), a strong NIR photothermal probe, which was confirmed
by our previous research.36 The photothermal probes were then exploited to generate heat under
the laser irradiation, and the vapor pressure within the immuno-PT-Chip acted as a powerful
microfluidic driving force to actuate on-chip movements of loaded immunosensing samples. The
schematic illustration is shown in Figure 6.1, representing a typical nanomaterial-mediated
immuno-PT-Chip using PB NPs and graphene oxide (GO) as photothermal probes. Some
fundamentals of using photothermal effects as the driving force were investigated previously by
our group.125
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Figure 6.1: Schematic illustration of an immuno-PT-Chip based on PB NPs- and GO-mediated
photothermal effects.

Based on this principle, with increasing amounts of target proteins, more Fe3O4 NPs were
immobilized and produced more photothermal probes, therefore leading to increased heat and
vapor pressure as well as elongated moving distances. As such, the immunosensing signals were
converted to visual bar charts on the immuno-PT-Chip. The quantitation of biomolecules was
achieved by visually reading the colored flowing distance on the immuno-PT-Chip, without the
aid of any bulky and expensive instruments. As a model target, a cancer biomarker, the prostate-
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specific antigen (PSA) was spiked in different media (the PBS buffer and normal human serum
samples) and detected on this immuno-PT-Chip. Visual quantitative measurements were
obtained with the limits of detection (LODs) of 2.0 and 2.1 ng/mL, when PSA was spiked in the
PBS buffer and serum samples, respectively. The sensitivity for the on-chip instrument-free
detection of PSA met the clinical requirement of prostate cancer diagnostics. This method was
further validated by testing spiked PSA in human whole blood samples, with satisfactory
analytical recoveries in the range from 89.1% to 92.5%. The immuno-PT-Chip provides
numerous advantages over conventional V-Chips by decreasing the material cost, simplifying the
assembly process, and applying a remotely controllable photothermal microfluidic driving force.
By combining nanomaterial-mediated photothermal effects with microfluidic LOC devices, the
immuno-PT-Chip has great potential in the exploration of novel POC diagnostic tools for broad
applications.
6.2

Experimental section

6.2.1 Materials and reagents
Most chemicals and reagents used in this work were listed in Section 2.1 (Chapter 2).
Fresh human whole blood was purchased from Zen-Bio (Morrisville, NC, US) and was tested by
FDA (U.S. Food and Drug Administration)-licensed tests, showing negative results in relevant
items (e.g. HCV). The concentrations of antibodies and antigens were determined via a
NanoDrop spectrophotometer (Sigma-Aldrich, St. Louis, MO, USA). Unless otherwise noted, all
chemicals were used as received without further purification. Milli-Q water (18.2 MΩ•cm) was
used for all reagent preparation from a Millipore system (Bedford, MA, US). The pH values of
all buffer solutions were determined using a pH meter purchased from Fisher Scientific (Model
AB15, Hampton, NH, US).
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A microplate reader (Molecular Devices, LLC, Sunnyvale, CA, US) was used in the UVvis characterization. A laser diode (808 nm, MDL-III-808, purchased from Opto Engine,
Midvale, UT, USA) was used as the NIR light source. All images were taken using a smartphone
(iPhone 7) in ambient temperature and natural light conditions.
6.2.2 Fe3O4 NPs-mediated immunosensing procedures
The Fe3O4 NPs-labeled secondary antibody was synthesized freshly, and the synthetic
procedures were described in Section 2.2 (Chapter 2).
The Fe3O4 NPs-mediated immunosensing process was performed according to a modified
procedure.36 Basically, 100 µL of 30 µg/mL monoclonal mouse anti-human PSA antibody
(primary antibody) was incubated overnight at 4.0 °C in a PCR tube. Then 200 µL of 5% BSA
blocking buffer was added to block the unbinding sites for 30 min at 37 °C. Different
concentrations of standard PSA solutions (100 µL) were prepared in the PBS buffer and
incubated in the above tube for 1.0 h at 37 °C, followed by thoroughly washing. The polyclonal
anti-human PSA antibody (secondary antibody) conjugated Fe3O4 NPs (100 µL) were added and
allowed for further incubation for 1.0 h at 37 °C. After washing thoroughly, the tubes carrying
immunosensing samples were obtained for the nanoparticle transformation process.
The nanoparticle transformation from Fe3O4 NPs to Prussian blue nanoparticles (PB NPs)
was achieved through the complexation reaction between ferric ions and ferrocyanide ions.125
The nanoparticle transformation reaction is illustrated in Figure 6.2. Briefly, 120 µL of HCl
solution (0.1 M) was added to a PCR tube after the immunosensing, which introduced Fe3O4
NPs. The mixture was under ultrasonication for 0.5 h at room temperature. The K4[Fe(CN)6]
aqueous solution (30 µL, 90.0 mM) was used to facilitate the complexation reaction under acidic
conditions to produce PB NPs.
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In the validation and specificity tests, different concentrations of PSA were spiked in 5fold diluted normal human serum samples and 10-fold diluted fresh human whole blood samples,
respectively. The interfering substances, containing hepatitis B surface antigen (HBsAg),
carcinoembryonic antigen (CEA), and immunoglobulin G (IgG), were chosen at 10-fold higher
concentrations (80 ng/mL), which were also prepared in 5-fold diluted normal human serum
samples and 10-fold diluted fresh human blood samples, respectively.

Figure 6.2: Schematic illustration of the transformation reaction from Fe3O4 NPs to PB NPs.

111

6.2.3 Fabrication of the PMMA/PDMS hybrid microfluidic device
The PMMA/PDMS hybrid microfluidic device was fabricated at the whole size of 7.5
cm2. It contained three layers: a top PDMS lid, a middle PDMS layer, and a bottom PMMA
layer. Both PDMS layers were fabricated via soft lithography. Essentially, the mixture of the
liquid PDMS curing and base reagent (weight ratio of 1:8.5) was stirred vigorously on a
mechanical stirrer (IKA RW16, VWR, Radnor, PA, US). The precursor mixture was then
transferred into Petri dishes (14 g per dish) and degassed in a vacuum desiccator for 30 min to
remove any air bubbles. After incubation at 50 °C for 30 min, the solid and flexible PDMS slices
(2.0 mm in thickness) were peeled off from the petri dish. The obtained PDMS slices were then
cut to the desired shapes serving as the middle layer and the top lid. The inlet and outlet
reservoirs were produced by punching the PDMS slices using biopsy punches, obtaining the
diameters of 0.35 cm and 0.40 cm, respectively.
The PMMA patterns were designed with Adobe AI software as shown in Figure 6.3A and
fabricated using the laser cutter. The PMMA sheets with a thickness of 1.5 mm were used to
create reservoirs and microchannels. At the laser power of 50% and the speed of 25%, the
reservoirs were obtained having a diameter of 0.35 cm and a depth of 830 µm. At the power of
40% and the speed of 30%, the microchannels were created with a total length of 50 mm, a width
around 250 µm, and a depth of 300 µm. Individual on-chip rulers were customized as scale bars
near each microchannel, and each unit was equivalent to 2.0 mm in practice.
For the hybrid chip assembly, two PDMS slices and the patterned PMMA layer were
placed in order after cleaning, which were reversibly attached based on the self-adhesion.213 As
illustrated in Figure 6.3B, the bottom PMMA layer was sealed by properly aligning with the
middle PDMS layer, while increasing the volumes of reservoirs. After loading the
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immunosensing solution, the inlets were sealed by the top PDMS lid, while the outlet reservoirs
were connected to the atmosphere.

Figure 6.3: The PMMA/PDMS hybrid immuno-PT-Chip. (A) The designed patterns on the
bottom PMMA layer. (B) Three-layer assembly of the immuno-PT-Chip.
6.2.4 Visual quantitative detection of PSA on a PDMS/PMMA hybrid immuno-PT-Chip
The photothermal effect-driven PMMA/PDMS hybrid microfluidic chip (immuno-PTChip) was designed and fabricated for the instrument-free photothermal detection of PSA.
The visual quantitative detection of PSA was based on the Fe3O4 NPs-mediated
photothermal effect. Particularly, 4 µL of blue food dye solution was added into the above
immunosensing solution for enhanced visualization of fluid movements. Each inlet reservoir on
the immuno-PT-Chip was loaded with 30 µL of the sample solution and then sealed with the top
PDMS layer. Four individual reservoirs containing sample solutions were exposed to the NIR
laser at the power density of 2.21 W/cm2 for 5 min. The increasing vapor pressure originated
from the photothermal probe (PB NPs), propelled the pre-loaded samples to flow through the
microchannels. Upon the laser irradiation for 5 min, the moving distances of fluid flowing were
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observed and recorded directly as bar charts using a built-in on-chip ruler on the immuno-PTChip. Visual quantitative detection of target PSA was achieved by reading the on-chip moving
distance (ΔL, 1 a.u. = 2.0 mm), derived from the nanomaterial-mediated photothermal effects.
6.3

Results and discussion

6.3.1 Working principle
The Fe3O4 NPs-mediated photothermal effect has been integrated with the PDMS/PMMA
hybrid immuno-PT-Chip for visual quantitative detection of a cancer biomarker PSA. As shown
in Figure 6.4, a typical sandwich-type ELISA has been applied, where the capture antibody is
first immobilized on a solid surface (e.g. a PCR tube). PSA, as the target antigen, specifically
binds with the capture antibody, and is then recognized by the Fe3O4 NPs-labeled detection
antibody via immune recognition interactions. In the presence of target PSA, the Fe3O4 NPs is
introduced into the sandwich immunoassay and used to produce PB NPs via a simple
complexation reaction, where the captured Fe3O4 NPs are first dissolved in acidic solutions to
release ferric ions (Fe3+) and then reacted with the potassium ferrocyanide (K4[Fe(CN)6]. The
obtained PB NPs with blue color have strong absorption in the NIR region and can be used as a
strong photothermal probe, which has been confirmed by our previous studies.36 However, in the
absence of target analytes, no specific binding between PSA and capture antibodies or Fe3O4
NPs-labeled detection antibodies. Likewise, Fe3O4 NPs could neither be captured nor converted
to PB NPs.
By preloading the PB NPs-containing immunosensing solutions to the ready-to-use
immuno-PT-Chip, quantitative detection of PSA can be achieved in a multiplex manner. Under
the NIR laser irradiation, the conversion from NIR light to thermal heat is triggered in the sample
solutions due to the nanomaterial-mediated photothermal effect. The heat is accumulated
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continuously and causes a dramatic increase in vapor pressure on the immuno-PT-Chip. The
increasing pressure acts as a microfluidic pumping force and drives sample solutions to move
through the microchannels. Hence, the bar-chart movement of sample solutions can be observed,
and the moving distance is recorded easily using the on-chip ruler. With the increasing
concentration of PSA from samples (e.g. human serum and whole blood), more Fe3O4 NPs are
captured and produce more PB NPs with darker colors, which leads to increased heat and the
elongated bar-chart moving distances on the immuno-PT-Chip. As such, the immunosensing
signals are converted to visual (i.e. color change from colorless to blue) and quantitative readouts
(i.e. on-chip moving distances), therefore resulting in the POC detection of PSA on the immunoPT-Chip.

115

Figure 6.4: Working principle of the visual quantitative detection of PSA based on the Fe3O4
NPs-mediated photothermal effect on the immuno-PT-Chip.
6.3.2 UV-vis characterization of the off-chip PSA immunosensing process
The off-chip Fe3O4 NPs-mediated immunosensing process was first investigated, and the
UV-Vis spectroscopic characterization was carried out on a 96-well microplate using the
microplate reader. Figure 6.5 shows the photographs and UV-vis characterization results at
different PSA concentrations spiked in the PBS buffer (pH 7.4, 10 mM) from 0 to 64.0 ng/mL.
After the transformation of nanoparticles, it was clearly observed that the sample color changed
from colorless to blue while increasing the concentration of PSA. The increasing absorption at
748 nm was also acquired representing the typical absorbances of PB NPs, which was consistent
with the previous studies.36,53 Hence, the results verified the successful transformation from
Fe3O4 NPs to PB NPs in the immunosensing solution. The calibration curve using colorimetric
signals as readouts was obtained with a linear relationship between the absorbance and the
logarithmical concentration of the target PSA. The detection concentration range was 2.0-64.0
ng/mL, with an R2 value of 0.988. The LOD in the colorimetric assay was calculated to be as low
as 1.0 ng/mL based on the sample signal-to-noise (S/N) ratio of 3, which was comparable to the
sensitivity of commercial PSA ELISA kits (LOD: 1.0 ng/mL).214 Besides, the strong and
enhanced absorption in the NIR region (e.g. at 808 nm) further provided a solid foundation for
the sensitive detection of biomarkers based on the photothermal effect.
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Figure 6.5: UV-vis characterization of the off-chip PSA immunosensing process in the PBS
buffer. (A) UV-vis spectra of immunosensing solutions after the transformation
from Fe3O4 NPs to PB NPs at different PSA concentrations (0-64.0 ng/mL) spiked
in the PBS buffer. (B) Calibration plot of the absorbance at 748 nm versus the
logarithm of the PSA concentration. Insets are the photographs of the above
immunosensing solutions. Error bars represent standard deviations (n = 3).

To validate this method, normal human serum samples were applied instead of PBS
buffer and spiked with different concentrations of PSA. It was noted that 5-fold diluted normal
human serum samples were used in these tests to avoid any unspecific binding from heterophilic
antibodies in real samples (e.g. serum and whole blood samples) in the immunoassays.215
Similarly, the Fe3O4 NPs-mediated immunoassay was employed to produce PB NPs. UV-vis
spectra were acquired for the off-chip immunoassay characterization, and the results are shown
in Figure 6.6. With increasing concentrations of PSA, an obvious and enhanced blue color
appeared in the sample solutions, confirming the successful off-chip immunoassay and the
subsequent nanoparticle transformation. Using the absorbances at 748 nm as the colorimetric
readouts, a calibration curve was obtained between the absorbance and the logarithm of the PSA
concentration, which were linearly correlated with the R2 value of 0.976. The detection range
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was 1.0-64.0 ng/mL, and the LOD was obtained as 1.3 ng/mL. These results indicated that good
sensitivity remained in the colorimetric detection of PSA using human serum samples, which
was comparable with the testing results using the PBS buffer (LOD of 1.0 ng/mL), confirming
good detection performance of this colorimetric method regardless of the spiking media.
Moreover, the increasing absorbances in the NIR range also verified the feasibility for on-chip
detection of PSA in serum samples based on Fe3O4 NPs-mediated photothermal effects.

Figure 6.6: UV-vis characterization of the off-chip PSA immunosensing process in serum
samples. (A) Photographs and (B) UV-vis spectra of immunosensing solutions after
the transformation from Fe3O4 NPs to PB NPs at different PSA concentrations (064.0 ng/mL) spiked in serum samples. (C) Calibration plot of the absorbance at 748
nm versus the logarithm of the PSA concentration. Error bars represent standard
deviations (n = 3).
6.3.3 Visual quantitative detection of PSA on the immuno-PT-Chip
After loading the immunosensing solutions to the center reservoirs, the visual quantitative
detection of PSA was performed on the PDMS/PMMA hybrid immuno-PT-Chip. Four individual
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sample reservoirs were irradiated at once by the 808 nm laser at the power density of 2.21
W/cm2. All sample solutions started to flow through microchannels due to the photothermal
effect-driven principle. It was noted that a yellow-colored background was used for the
convenience of observation of blue sample solutions. The fluid flowing could be easily observed
by the naked eye, and the moving distance (ΔL) through the microchannels was recorded as the
readout according to the designed on-chip ruler. As results are shown in Figure 6.7, with the
increasing PSA concentrations, the moving distances of sample solutions were clearly elongated
under the laser irradiation. Under the irradiation for 5 min, a linear relationship was obtained
between the moving distance and the logarithmical concentration of PSA in the range from 2.0 to
64.0 ng/mL, with the R2 value of 0.986. The LOD was determined to be 2.0 ng/mL based on the
S/N ratio of 3, meeting the criteria of clinical diagnostics with the cut-off PSA concentration of
4.0 ng/mL.81,125 The visual quantitative detection of PSA spiked in the PBS buffer was achieved
with convenient immunosensing readouts and high sensitivity.
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Figure 6.7: Visual quantitative detection of PSA in the PBS buffer using the PDMS/PMMA
hybrid immuno-PT-Chip. (A) Photographs of on-chip detection at different
concentrations of PSA spiked in the PBS buffer. Four parallel experiments were
conducted on a single immuno-PT-Chip. Red arrows indicate the end location of
bar-chart movements. (B) Calibration curve of the moving distance (ΔL) versus the
logarithmical concentration of PSA. Error bars represent standard deviations (n =
4). (1 a.u. = 2.0 mm. The laser irradiation time was 5 min. The laser power density
was 2.21 W/cm2.)
This photothermal immunosensing platform was also validated by testing PSA in human
serum samples. In the on-chip detection, under the NIR laser irradiation, the moving distance
(ΔL) was recorded with varying concentrations of PSA spiked in 5-fold diluted normal human
serum samples. The results in Figure 6.8 showed that the moving distances of sample solutions
were prolonged on the immuno-PT-Chip as the PSA concentration increased. The moving
distance was proportional to the concentration of PSA in spiked serum samples upon laser
irradiation for 5 min. There was a linear relationship between the ΔL and the logarithmical PSA
concentration in the range from 2.0 to 64.0 ng/mL, with the coefficient of determination as
0.986. The LOD was calculated to be 2.1 ng/mL based on the S/N ratio of 3, which could meet
the clinical threshold value of 4.0 ng/mL as well. The results proved that visual quantitative
detection of PSA could be achieved on the immuno-PT-Chip, even in complex media like human
serum samples without hurting the detection sensitivity.
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Figure 6.8: Visual quantitative detection of PSA using the PDMS/PMMA hybrid immuno-PTChip in spiked human serum samples. (A) Photographs of on-chip detection at
different concentrations of PSA spiked in human serum samples. Four parallel
experiments were conducted on a single immuno-PT-Chip. Red arrows indicate the
end location of bar-charts. (B) Calibration plot of the moving distance (ΔL) versus
the logarithmical concentration of PSA. Error bars represent standard deviations (n
= 4). (1 a.u. = 2.0 mm. The laser irradiation time was 5 min. The laser power
density was 2.21 W/cm2.)
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6.3.4 Specificity tests
To study the specificity and further validate the proposed photothermal immunosensing
platform (immuno-PT-Chip), 5-fold diluted normal human serum and 10-fold diluted fresh
human whole blood samples were selected and spiked with different concentrations of PSA for
on-chip tests. In addition, some common interfering substances, involving HBsAg, CEA, and
IgG with higher concentrations up to 80 ng/mL, were prepared and tested in a similar procedure.
Two concentrations of PSA, 4 ng/mL and 8 ng/ml were selected according to the commonly used
threshold concentration and the suspect level for clinical prostate cancer diagnostics.216-218 As
shown in Figure 6.9, only samples spiked with PSA had obvious moving distances in the range
of 3-6 a.u. (6.0-12.0 mm), whereas the blank samples containing serum or blood matrix media
displayed neglect moving distances, indicating negligent effects from the matrix media in the
detection of PSA. Besides, according to the t-test statistics, there was no significant difference in
the detection results when spiking the same concentrations (4.0 or 8.0 ng/mL) of PSA in serum
and whole blood samples, further proving that the matrix media had little influence on the
immunosensing results. Moreover, there were also no obvious bar-chart movements acquired
from other interfering substances compared to the PSA tests, showing high selectivity of the
photothermal immunosensing platform. The results demonstrated high specificity and high
tolerance to matrix samples for PSA detection using the immuno-PT-Chip. Also, this method is
advantageous over conventional colorimetric methods by avoiding the common color
interference issues from the real samples, like whole blood samples.
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Figure 6.9: Specificity tests for PSA detection on the immuno-PT-Chip in different matrix
media, including 5-fold diluted normal human serum and 10-fold diluted fresh
human whole blood samples. Other interfering substances were tested including
HBsAg, CEA, and IgG with the same concentration of 80 ng/mL. The media
(serum and blood) were used as blank samples. Error bars represent standard
deviations (n = 4). The symbol (ns) indicates no statistical significance in t-test (Pvalue > 0.05).
6.3.5 Analytical recovery
The analytical recoveries were studied for further validation of this method. The target
PSA was spiked in both serum and whole blood samples and detected on the immuno-PT-Chip
without further treatment of samples. By comparing the known spiked concentrations and the
detected concentrations of PSA on the immuno-PT-Chip, the analytical recoveries were
calculated and summarized in Table 6.1. It was found that the analytical recoveries with PSA
concentrations of 4 and 8 ng/mL in human serum were 91.3-91.9%, with the relative standard
deviations (RSDs) of 5.9% and 5.1%, respectively. The analytical recoveries obtained in spiked
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human whole blood samples were 92.5% to 89.1%, with the RSDs of 7.0% and 4.5%,
respectively. Overall, all the analytical recoveries were within the acceptable criteria for
bioanalytical method validation,158,219 indicating that the proposed immuno-PT-Chip could yield
reliable results with satisfactory interpretation for the detection of PSA even in the human whole
blood matrix.
Table 6.1: Analytical recoveries for the detection of PSA spiked in normal human serum and
human whole blood samples
Sample

PSA concentration (ng/mL)

Matrix

Recovery (%)

RSD (%)

3.65

91.3

5.9

8.0

7.35

91.9

5.1

3

4.0

3.70

92.5

7.0

4

8.0

7.13

89.1

4.5

No.

Spiking

Detected

Normal human

1

4.0

serum (n = 4)

2

Human whole
blood (n = 4)

6.4

Summary
In summary, a new immuno-PT-Chip has been developed for the immunoassay of cancer

biomarkers, which was driven by nanomaterial-mediated photothermal effects. By using this
immuno-PT-Chip, PSA as a model analyte could be detected rapidly and quantitatively with high
specificity and sensitivity in different spiked samples (i.e. the PBS buffer and the human serum
samples). The LOD was obtained as 2.1 ng/mL in normal human serum samples, which met the
cut-off requirement in clinical diagnostics for prostate cancers. This detection platform was
further validated by testing PSA in human whole blood samples, obtaining satisfactory analytical
recoveries in the range of 89.1-92.5%, demonstrating good analytical performance for biomarker
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detection even in the complex matrix. The introduction of nanomaterial-mediated photothermal
effects into bar-chart microfluidic chips opens new opportunities towards advances in various
bioassays, as well as for the exploration of photothermal reagents in versatile applications, such
as the diagnosis of early-stage cancers.
Additionally, several benefits can be drawn by applying this immuno-PT-Chip for POC
diagnostic applications. For instance, the fabrication of immuno-PT-Chip was simple and lowcost (the material cost of the immuno-PT-Chip is $0.40 for each assay) due to the use of
inexpensive materials (i.e. PDMS and PMMA). No specialized infrastructure (like a clean room)
and complicated assembly process are needed in comparison with current V-Chips. The
immuno-PT-Chip is also miniaturized (the 4-in-1 chip has a total size of 7.5 x 7.5 cm) and
portable, and can be used as a ready-to-use microfluidic platform for POC diagnostics,
eliminating the use of bulky and expensive analytical instrumentation. The produced signals (i.e.
on-chip bar-chart movements) are easy to visualize, read, and record, with no need for the trained
personnel and complex data analytics, allowing the quantitative instrument-free detection of
biomolecules. Also, the current designs of the immuno-PT-Chip contain four individual testing
regions and allow the versatile and multiplex detection of targets simultaneously with only onetime laser irradiation. Besides, compared to the gas-driven V-Chips, the immuno-PT-Chip
applying nanomaterial-mediated photothermal effects as the driving force has great potential for
testing various targets with precise controllability, which can be achieved by adjusting chip
designs and remotely tuning parameters of laser irradiation.
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Chapter 7: Conclusions and Perspectives

•

This chapter provides the conclusions and perspectives of the research work in
this dissertation.
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7.1

Conclusions
In this dissertation, nanomaterial-mediated photothermal effects have been studied and

successfully applied in the quantitative diagnostics of a variety of diseases, including infectious
diseases (TB and hepatitis C) as well as cancer (prostate cancer). This research work has
integrated nanotechnology, the photothermal effect principle, and microfluidics, which has
provided simple, convenient, and low-cost detection methods for both genetic analyses and
immunoassays at the point of care. In conclusion:
1. By introducing nanomaterial-mediated photothermal effects into the genetic analysis,
AuNP aggregation was used as a strong photothermal probe, and the target nucleic acids (e.g.
MTB DNA) can be quantitatively detected, for the first time, by only using an inexpensive and
common thermometer as the signal recorder. There was no need for any expensive and bulky
specialized instruments in this method, which provided a simple, low-cost, and universal
quantitative detection platform for various nucleic acids.
2. On the basis of simple DNA immobilization on paper via a one-step surface
modification method, the photothermal genetic analysis was achieved on a low-cost
paper/polymer hybrid microfluidic device, which employed ox-TMB as a strong photothermal
probe. The detection platform had numerous benefits for POC disease diagnostics, such as
miniaturization, portability, low cost, low reagent consumption, reduced detection time, and no
issues of color interference.
3. In addition to genetic analysis, the applications of nanomaterial-mediated photothermal
biomolecular

quantification

strategies

have

been

further

extended

to

protein-based

immunoassays using ox-TMB as the photothermal probe. With the use of a portable and
inexpensive laser pointer, the target proteins (HCVcAg) were detected rapidly with high
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specificity and sensitivity by using a common thermometer. Quantitative disease diagnosis was
achieved based on temperature readouts, providing good analytical performance even in human
serum samples.
4. By integrating the photothermal immunosensing strategy on a low-cost polymer hybrid
microfluidic device, an immuno-PT-Chip, has been developed for the equipment-free
photothermal detection of protein biomarkers (PSA) using PB NPs as a strong NIR photothermal
probe. The POC photothermal immunoassay can be achieved by directly reading the visual barchart movement on immuno-PT-Chip, which was driven by photothermal microfluidic pumping.
There was no need for any costly and advanced analytical instruments in the method, even a
thermometer. High sensitivity and specificity were obtained in the POC detection of PSA even in
a complicated matrix (e.g. human serum and whole blood samples), which met the clinical
requirement for prostate cancer diagnosis.
5. Overall, the nanomaterial-mediated photothermal effects have demonstrated great
potential for quantitative detection of biomolecules using a thermometer, including nucleic acids
and protein biomarkers, which have been successfully applied in visual quantitative disease
diagnosis for both infectious diseases and cancers.
6. With the integration of microfluidic technology, the photothermal bioassays have been
further improved for broader applications for simple, low-cost, and even equipment-free POC
disease diagnostics.
7.2

Perspectives

7.2.1 Fully integrated diagnostic platforms
The development of fully integrated microfluidic devices can remarkably improve the
convenience, portability, and detection throughput of the photothermal bioassays, therefore,
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providing a promising “Sample-in-Result-out” POC diagnostic platform. To achieve this goal,
several integration strategies can be applied as listed below.
One important aspect is to integrate the light source (i.e. the laser irradiation system) on
the photothermal bioassays. With the rapid development of commercially available lasers, the
use of a miniaturized NIR laser with built-in batteries can provide a low-cost and space-saving
experimental setup. In this regard, customized designs of detection boxes with a complete light
irradiation system will be greatly beneficial for convenient, standardized, and user-friendly
diagnostic process, which allows further improvement of the photothermal POC diagnostic
platforms.
Another improvement can be made to integrate a dedicated temperature measuring
system in the photothermal diagnostic method. Due to continuous heat dissipation during
temperature measurement, the current biosensing results have been obtained and recognized as
“bulky” temperature signals, which rely on the balance between photothermal heat generation
and heat loss. It is meaningful and of great significance to study the “localized” heat generation
and temperature increase owing to nanomaterial-mediated photothermal effects. The integration
of dedicated thermometers (e.g. in situ thermometers) or thermometer-like indicators (e.g.
temperature-responsive labels or hydrogels) can provide precise measurement of localized
temperature in the photothermal bioassays. These abovementioned tools will greatly minimize
temperature variations caused by the heat loss in the photothermal measurement. Moreover,
other strategies including adding a thermal insulation layer in the photothermal measuring setup
can be included to further prevent heat loss. As such, the improvement of sensitivity in
photothermal bioassays can be also expected.
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7.2.2 Future direction of different photothermal bioassays
In addition to the improvement of the experimental setup, there are also different
strategies that can be integrated based on specific target biomolecules in the photothermal
bioassays, in order to achieve a whole POC diagnostic platform. For example, in the
photothermal genetic analysis, one specific effort can be made to integrate an on-chip nucleic
acid extraction unit on the current paper/polymer microfluidic device. With the integrated chip,
nucleic acids can be extracted from practical samples directly and then analyzed easily on a
single chip.
Another future approach is to integrate the whole immunoassay on microfluidics and
improve the current immuno-PT-Chip. Some specific strategies are listed herein. First, to
simplify the immunoassay, capture antibodies can be immobilized on the microfluidic chips
through proper surface modification procedures either via chemical bonding or physical
adsorption (similar to the work presented in Section 4). Second, to enhance the integration of
microfluidics, the on-chip incubation of antigens and antibodies can be achieved by integrating
different compartments, including sample introducing inlets, reagent mixing/incubation zones,
photothermal detection zones, waste reservoirs/outlets, etc. Hence, by simply reading the barchart movement, high-throughput and multiplex diagnostic results can be obtained on the
integrated microdevice without the aid of any instruments. Besides, the abovementioned
dedicated temperature measuring system, such as the temperature-responsive labels, can also be
incorporated on the microfluidic platforms to further improve the convenience and portability
during the photothermal measurement.

131

7.2.3 Validation tests of clinical samples
The current validation tests have been conducted by spiking target biomolecules in
normal human serum and/or human whole blood samples. To further confirm the reliability and
test the diagnostic performance, clinical validation of the nanomaterial-mediated photothermal
quantitative biosensing strategy is expected to be performed based on clinical diagnostic
criteria.220 For instance, by testing a large number of patients’ specimens (e.g. sputum, swabs,
serum, blood, etc.), the detection results from the proposed method can be obtained in
comparison with those from clinical laboratories or hospitals using standard methods. Systematic
studies of these comparative results using statistical techniques will provide an accurate and
comprehensive assessment of the proposed diagnostic method regarding its robustness,
reproducibility, sensitivity, specificity, overall agreement, etc., which has great potential for
further translational development of the photothermal biosensing technology.
7.2.4 Integration of advanced data analysis techniques
Nowadays, the supplementation of high tech-based platforms (e.g. machine learning) has
drawn numerous benefits by providing simple yet high-throughput data acquisition, processing,
and analysis. It is of great interest and value to incorporate advanced analytical models (such as
Smartphone App for photothermal diagnostic interpretation) in the quantitative detection of
biomolecules for disease diagnosis, particularly when handling a large number of tests and
datasets. With the assist of these advanced data processing techniques, the photothermal
bioassays can be fully developed with superior features for POC disease diagnostics, including
high-throughput outcomes, remote analysis systems, user-friendly interfaces, etc.
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